Healthcare Asia 2025

Page 1


PUBLISHER & EDITOR-IN-CHIEF Tim Charlton

EDITORIAL MANAGER Tessa Distor

PRINT PRODUCTION

EDITOR Eleennae Ayson

LEAD JOURNALIST Gwyneth Marie Bejer

JOURNALISTS Alec Maquiling Ibnu Prabowo

GRAPHIC ARTIST Emilia Claudio

EDITORIAL ASSISTANT Vienna Verzo

COMMERCIAL TEAM Jenelle Samantila Dana Eunise Cruz

ADVERTISING Shairah Lambat shairah@charltonmediamail.com

AWARDS Julie Anne Nuñez-Difuntorum awards@charltonmediamail.com

ADMINISTRATION Eucel Balala accounts@charltonmediamail.com

EDITORIAL ha@charltonmedia.com

FROM THE EDITOR

Several hospitals in Asia have moved beyond pilot phases and are now implementing innovation at scale. At Asian Hospital in the Philippines, the CyberKnife system already reduces the average number of cancer treatment sessions from 30 to five by tracking patient movement in real time. CEO Beaver Tamesis talks about this on page 22.

In Malaysia, Mahkota Medical has implemented a smart ward system that reduces manual data entry and saves nurses 1.5 hours per patient. CEO Teo Chin Yee outlines its operational impact on page 24.

Meanwhile, in Singapore, Sengkang General Hospital’s robotic inventory prepares surgical trays with zero manual intervention. Find out more on page 18.

SINGAPORE

Charlton Media Group 101 Cecil St. #17-09 Tong Eng Building Singapore 069533 +65 3158 1386

HONG KONG

Charlton Media Group Room 1006, 10th Floor, 299QRC, 287-299 Queen’s Road Central, Sheung Wan, Hong Kong

MIDDLE EAST

FDRK4467, Compass Building, Al Shohada Road, AL Hamra Industrial Zone-FZ, Ras Al Khaimah, United Arab Emirates

www.charltonmedia.com

PRINTING

Times Printers Private Limited 18 Tuas Avenue 5, Singapore 639342 www.timesprinters.com a member of Times Publishing Limited

Can we help?

Editorial Enquiries: If you have a story idea or press release, please email our news editor at ha@charltonmedia.com. To send a personal message to the editor, include the word “Tim” in the subject line.

Media Partnerships: Please email ha@charltonmedia.com with “Partnership” in the subject line.

Subscriptions: Please email subscriptions@charltonmedia.com.

Healthcare Asia is published by Charlton Media Group. All editorial materials are covered by copyright and may not be reproduced without consent. Contributions are invited, but copies of all work should be kept as Healthcare Asia can accept no responsibility for loss. We will, however, take the gains.

Distributed to all CxO, board levels, doctors, and healthcare professionals of major private/public hospitals and health ministries in ASEAN and Hong Kong.

However, as digital tools become embedded in clinical workflows, new risks are surfacing. Healthcare data breaches have doubled in the last three years. Read the full story on page 7.

Other developments in this issue reflect systemic questions: How much of Southeast Asia’s healthcare growth will be tied to medical tourism, and why are private hospitals in the Philippines being advised to curb capital spending? Read more on pages 6 and 16. What are the structural bottlenecks in organ transplantation, and how are hospitals trying to overcome them? Learn more from our hospital tour with The Medical City on pages 12 to 13.

To cap it all off, healthcare excellence was on full display at this year’s Healthcare Asia Awards, Medtech Awards, and Pharma Awards. Flip to pages 56 to 64 to meet the trailblazers transforming patient care across the region. Congratulations to all the winners!

HealthcareAsia is also the media sponsor for the following events:

News from healthcareasiamagazine.com

Daily news from Asia

MOST READ

HMI Medical rebranding marks shift to integrated care

HMI Medical is building an integrated healthcare network centred on people, digital innovation, and holistic wellness as part of a strategy that also involves mergers and acquisitions to drive growth. The rebranding of the private healthcare company aims to unify all its services under one identity.

India’s diagnostic imaging market to exceed $7b by 2033

India’s diagnostic imaging market is projected to surpass $7b by 2033 at a compound annual growth rate of approximately 7%, according to GlobalData. This is due to various factors such as rising healthcare expenditure, an increasing chronic disease burden, and greater demand for accessible diagnostic solutions.

Singapore's state health workers need work-life balance

Singapore should prioritise work-life balance in the public health sector to attract and retain local talent amidst the growing medical demands of its ageing population, analysts said. In January, the Ministry of Health said 37,000 health professionals in the public sector would get salary increases by mid-year.

Australian gov’t amends nurse and midwife ratios in Victoria

The Australian government is introducing legislative amendments to strengthen nurse and midwifeto-patient ratios across Victoria. The new ratios will apply to metropolitan and regional intensive care units, emergency departments, highdependency units, coronary care units, and maternity wards.

Philippines increases package rate for hemodialysis services

The Philippine Health Insurance Corporation (PhilHealth) has increased the hemodialysis package rate from $71.35 (PHP4k) to $113.28 (PHP6.35k) per session. According to the Southeast Asian nation's Department of Health (DOH), the approved rate will apply to both public and private dialysis units.

Malaysian pharmaceuticals to project modest growth amidst new reform

The Malaysian pharmaceutical market is expected to grow moderately, with sales forecast to reach $2.3b this year, though growth is projected at 5.8% in US dollar terms due to currency fluctuations, said BMI. A new procurement system aims to address medicine shortages and supply chain disruptions.

Your Strategic Healthcare Business Partner in Asia Pacific and Beyond

DKSH is the one-stop-shop for healthcare companies looking to grow their business in Asia Pacific. We provide both integrated solutions as well as specialized services, customized to what your business needs, so you can focus on your strengths and leave the rest to us.

• Distribution & Logistics

• Commercial Services

• Regulatory Services

• Digital Analytics and Insight

• Patient Solution Program

• Software integration

• Sustainable Supply Chains

Contact us today to discover new opportunities.

www.linkedin.com/company/dksh

Southeast Asia battles for a bigger share of the $35.9b medical tourism market

Travellers seeking life-altering medical procedures are increasingly eyeing Southeast Asia as a medical tourism destination, given the potential cost savings and access to cutting-edge treatments, whilst avoiding long wait times back home.

The region is on track to solidify its position as a key medical tourism player, with more hospitals and clinics that are home to renowned doctors and specialists investing more heavily in high-tech medical devices, RHB Investment Bank Bhd reported.

Rising demand

Major healthcare providers, including Bangkok Dusit Medical Services, IHH Healthcare, and KPJ Healthcare are banking on rising demand in the region, which captures a third of the world’s tourists seeking affordable and high-quality treatments, it said.

“Beyond value-for-money service offerings, the rise of qualified professionals, in our view, will continue to drive the medical tourism industry in Southeast Asia,” RHB said.

“This, in turn, should benefit prominent healthcare service providers in the region.”

The global medical tourism market is expected to be worth $35.9b by 2032, or a compound annual growth rate of 12.2%, according to Market.US. Medical tourism can save patients as much as 70% of the cost of care compared with the US.

RHB said Malaysia and Thailand are the biggest winners. Thailand leads the region in revenue at $850m. Malaysia’s medical tourism revenue was $ 444m, whilst Singapore’s was estimated at $270m, it added.

“As the strong SGD made Singapore a less attractive medical tourism destination, we see Thailand and Malaysia benefiting from the shifting of interest from medical tourists seeking value-for-money quality healthcare services; they will also benefit from visa-free travel to both countries,” it added.

Regional moves

Thailand recently signed a deal with Saudi Arabia to attract medical tourists, and relaxed medical visa regulations last year to make healthcare more accessible to international patients. Malaysia’s advantage, meanwhile lies in specialisations such as in-vitro fertilisation, with the highest success rate achieved by Alpha IVF Group, a fertility care provider based in Selangor.

Singapore is also investing in fertility treatments in response to declining birth rates and an ageing population, with a new fertility hub by Thomson Medical set to open in the latter half of the year.

The city-state’s strength further lies in cutting-edge treatments such as proton therapy and its specialised expertise in oncology, cardiology, and organ transplants.

Malaysia has also signed a deal with China, extending visa-free travel until end-2025. “Such a policy is expected to have a positive spillover effect on medical tourism, as China tourists account for 5% of the country’s medical tourism revenue,” RHB said.

RHB said a medical tourist’s main

consideration has always been centred on the cost of treatment. “On the back of stubbornly high inflation and long waiting times at hospitals in developed countries — in the US and UK, the waiting time for treatment could reach as long as 52 weeks — medical tourists are seeking cross-border healthcare alternatives to fulfil their needs,” it added.

For example, a patient from the US could save as much as 80% in Malaysia, 75% in Thailand, and 40% in Singapore, depending on the type of treatment itself, RHB said. In Thailand, which is known for plastic and reconstructive surgery services, the average cost of a facelift is $2,400 versus $19,000 for a similar procedure done in the US.

Moreover, recent shifts in US trade policy, particularly tariffs on imported surgical tools, diagnostic equipment, and protective gear are raising costs for healthcare providers, widening the price gap with overseas care and pushing more of the country’s patients to seek treatment abroad, according to a GlobalData report.

“Whilst the intended impact of tariffs may not have been to affect healthcare, they do shape patient behaviour,” said Alexandra Murdoch, senior medical analyst at GlobalData.

Trust and confidence

A report by the Medical Tourism Association this year showed that trust influences 97% of patient decisions to pursue healthcare overseas. About 63% of patients said they would choose a healthcare provider with an international accreditation.

“This underscores the profound impact accreditation has on reinforcing patient trust and confidence,” it said.

Trust and accreditation remain a challenge for Indonesia’s less established medical tourism industry, given its lack of brand recognition and healthcare infrastructure, RHB said. The country loses billions of dollars in revenue as many of its citizens seek medical treatment abroad, it added.

To stem the outflow, the government is developing a 41-hectare medical tourism special economic zone in Sanur, Bali and has allowed foreign doctors to practise in Indonesia. There is also a proposal to streamline the employment process for foreign doctors and Indonesian graduates from foreign institutions.

Meanwhile, the Medical Tourism Association report noted that whilst quality and trust dominate patient decisions, 28.8% of the respondents said they are also influenced by cost.

A US patient can save as much as 80% in Malaysia, 75% in Thailand, and 40% in Singapore
The global medical tourism market is expected to be worth $35.9b by 2032
HOSPITALS

Hospitals need unified strategy against ransomware

Hospitals should integrate their defenses into a single platform as data leaks in healthcare doubled in three years, according to analysts.

“Over 200 new internet-facing and cloud services are added to the healthcare sector every month,”

Steven Scheurmann, regional vice president for ASEAN at Palo Alto Networks, Inc., told Healthcare Asia. “This increases the number of potential entry points for attackers.”

By reducing security risks and monitoring their systems continuously, healthcare organisations could boost their defences before

threats turn into crises, he said in an exclusive interview.

Doubled data leaks

Healthcare data leaks have doubled in three years despite a 50% increase in tracked leak sites, according to a Google Threat Intelligence Group report. Ransomware-driven disruptions have threatened the lives of patients and the broader healthcare supply chain, it added.

One example is the PHOBOS ransomware attack in February 2024 that targeted 25 Romanian hospitals and disrupted more than 100 healthcare facilities. Similarly,

a Hong Kong-based hospital was thrown into disarray after a cyberattack in April 2024.

The industry was the second-most affected sector by ransomware in the first half of 2024, said Scheurmann. “A key reason for this is the sector’s rapidly evolving attack surface.”

Patients can lose confidence in hospitals due to repeated data compromises, he noted.

“This can slow down technological adoption and innovation,”

Scheurmann said. “Without stronger security measures, hospitals risk operational instability and, ultimately, compromised patient care.”

Understanding tactics

Strong protection requires tested backup plans and staff training to build a security-conscious culture, said Lim Yihao, lead threat intelligence advisor for Japan and Asia-Pacific at Google Threat Intelligence Group.

“As employees are often the first line of defence against any cyber attack, awareness and understanding of tactics commonly deployed by threat actors is important,” he said in a separate interview.

Without stronger security measures, hospitals risk operational instability and compromised patient care

Scheurmann noted that phishing and social engineering attacks continue to be amongst the most effective ways for cybercriminals to gain access to hospital networks. “Business email compromise was one of the top three most common investigations in the healthcare sector in 2024," he continued.

US FOREIGN AID CUTS PRESSURE HEALTH SYSTEMS IN EMERGING MARKETS

Ongoing cuts in foreign funding from developed countries will increase pressure on health systems in emerging markets, negatively impacting emergency preparedness and the delivery of services and medical products, according to a BMI report released in April.

The US, through agencies such as USAID, has historically been the largest donor for global health programmes, including efforts to combat HIV, malaria, and tuberculosis in low and middle-income countries.

“Since President Trump took office on 20 January, at least 38% of USAID funds have been cut compared to FY 2024-25 obligations, according to the Center For Global Development,” the report said.

Specifically, funding for HIV prevention and

treatment has been reduced by 20%, whilst funds for malaria control have been cut by 36%.

Furthermore, programmes addressing reproductive, maternal, and child health have faced cuts exceeding 95%.

The World Health Organization reported that a third of its country offices encountered shortages of medicine and health products for certain diseases and conditions.

The most affected areas include vaccines, outbreak detection and reporting, noncommunicable diseases, sexually transmitted infections, and neglected tropical diseases.

“We anticipate continued disruptions in the supply and procurement of healthcare products, including HIV antiretrovirals, preexposure prophylaxis, anti-malaria drugs, routine immunisations and diagnostic tests,” it added.

Over 200 new internet-facing and cloud services are added to the healthcare sector monthly
Budget cuts for health programmes
Source: WHO, BMI
Steven Scheurmann
Lim Yihao
TECHNOLOGY

3D-PRINTED SKIN OFFERS NEW HOPE FOR BURN VICTIMS

Researchers at Concord Hospital in New South Wales, Australia, have developed a technique that uses a patient’s own cells to 3D-print skin directly onto wounds.

According to the state government, the clinical trial involves applying 3D-printed skin to wounds surgically created when harvesting skin grafts to treat burn injuries.

The technique was developed in collaboration with the Skin Laboratory at the hospital’s burns unit. The process begins with isolating skin cells from the patient. These cells are then used in a robotic 3D printer to generate new skin tissue tailored to the individual.

Poor wound healing can often lead to significant scarring, especially with large burns, affecting patients’ long-term quality of life and placing pressure on healthcare systems.

“We know people with serious burns face a range of medical complications,” said Minister for Health Ryan Park

“This breakthrough offers a promising new approach to accelerate recovery, reduce pain, and improve long-term outcomes for patients,” Park added.

Clinical trials

According to early studies, 3D-printed skin encourages faster healing and reduces pain for burn victims. The next phase of the trial will assess whether this method is suitable for direct application to burn sites and deeper wounds.

The technique uses technology developed by Australia-based Inventia Life Science, which allows biomaterials to be precisely printed onto wounds to assist in tissue repair.

The company recently received $2.24m (A$3.5m) through the government's Medical Devices Fund to further develop its Ligo Surgical Robot, a device designed to rebuild soft tissue directly at the treatment site, offering an alternative to complex grafting procedures.

NUHCS trains doctors in less invasive valve fix

PROCEDURES

The National University Heart Centre Singapore (NUHCS) is training the region’s specialists on a minimally invasive procedure to replace the aortic heart valve, which has been proven to be superior to open surgery for patients with an immediate risk of complications.

The centre targets cardiologists and surgeons from countries where the procedure — called transcatheter aortic valve implantation (TAVI) — is still in its early adoption phase, Ivandito Kuntjoro, a senior consultant cardiologist at NUHCS’s Department of Cardiology, told Healthcare Asia

“The Philippines, Thailand, and Malaysia are doing TAVI,” he said. “But [NUHCS] has been doing this for 10 years and has performed a high number of procedures.”

The demand for the procedure continues to rise, with the global market valued at $7.01b in 2024 and expected to grow 10.1% annually to $12.41b by 2030, according to a Next Move Strategy Consulting report.

Kuntjoro, who is the director of NUHCS’s Structural Heart Programme, said the centre provides training that

includes hands-on experience and the management of complex structural heart cases at clinics, hospitals, and intensive care unit settings.

They train one fellow a year and funding support comes from the hospital and, at times, from the trainee's home institution, he said.

NUHCS uses 3D simulation for the training. “Each patient undergoes a CT (computed tomography) scan, allowing us to generate a detailed 3D analysis of the access route and the aortic annulus geometry,” Kuntjoro said.

The procedure is done in patients with aortic stenosis, where one of the heart’s valves narrows, making it harder for blood to flow to the rest of the body. Symptoms include chest pain, breathlessness, or fainting episodes if left untreated.

“One key sign is a heart murmur,” he told Healthcare Asia

“In Singapore, where the population is ageing, the condition’s incidence is notable,” the cardiologist said.

“According to general estimates in other populations, the prevalence of aortic stenosis in people aged 65 and older can range from 2% to 7%," Kuntjoro told the magazine.

When people think about heart issues, they often assume it's all about heart attacks, but valve problems are common too

Training and early diagnosis

The centre allows trainees to observe live procedures. “The day before [the procedure], we hold didactic training, covering the procedure's indications, benefits, side effects, and other key information," he continued.

"Our consultant also serves as a TAVI proctor, travelling across the region to train and supervise new centres or assist with complex procedures at established centres,” he added.

NUHCS uses artificial intelligence (AI) to help analyse ultrasound images for diagnosing heart problems. Whilst the centre does not use AI for TAVI itself, doctors continue to adopt the latest tech, including the newest valve generations, he said.

Kuntjoro, who is a clinical assistant professor at the National University of Singapore’s Yong Loo Lin School of Medicine, urges early detection, particularly for aortic stenosis.

"When people think about heart issues, they often assume it’s all about heart attacks or high blood pressure, but valve problems are common too,” he said. “People need to recognise the symptoms, as delayed treatment can lead to permanent heart damage.”

The programme trains one fellow a year to do TAVI
Ivandito Kuntjoro

National Cardiovascular Center Harapan Kita

Jakarta, Indonesia

Experience World-Class

Cardiovascular Care

Our cardiovascular services reach patients globally. As the leader of the Cardiovascular Referral Network in Indonesia and Asia, we offer top-tier care, education, and research meeting international standards.

Committed to world-class excellence, enriching our practice with diverse expertise. Patients worldwide are invited to experience our exceptional care and hospitality

With our expertise and dedication, exceptional cardiovascular care is always within your reach, wherever you are in the world.

Our Services Include :

Leadless pacemaker/ICD/CRT

3D catheter ablation

Cryoablation

LAA closure

Bentall prosedure

MICS (Valve, Congenital, Coroner)

Complex congenital heart surgery

EVAR / TEVAR

Transcatheter Aortic Valve Implanation

Complex PCI

Zero Fluoroscopy CHD Intervention

Cardiovascular Multimodality Imaging : CT, MRI, Nuclear cardiology

Mitral Clip

Endovenous Laser Ablation

Connect With Us!

Priority Service (An exclusive healthcare service that offers comfort and quick access)

External Counter Pulsation

Home and Palliative Care

Advanced Heart Failure

HeartFit Gym (A structured exercise program designed to improve fitness and heart health)

HeartFit Diet (A heart-focused dietary program tailored to boost cardiovascular health and elevate overall quality of life)

Genomic Services

Clinical Research Unit

Global Partnership Networking

Get our latest news, packages, information, promos and health trends through below

0811-911-5045

Proudly the flagship hospital of OHB, OMSMC provides comprehensive care - from health screenings to advanced medical imaging - supported by modern facilities like the cathlab, endoscopy unit, OT, and premium suites.

Our dedicated team ensures seamless coordination across specialties, from early diagnosis to advanced surgical interventions. At OMSMC, your health and comfort come first.

Experience exceptional healthcare, wholeheartedly

HeartFit Gym & Diet
Fetal Echocardiography

China International Import Expo Bureau achieves trade liberalisation, economic globalisation

The China International Import Expo Bureau has solidified its commitment to opening the Chinese market to the world and promoting international cooperation.

China, being the secondlargest global economy, importer and consumer, presents enormous potential for growth in imports and consumer markets as its consumption continues to rise. The country expects to import products and services worth more than $10 trillion over the next five years, which is a historic opportunity for businesses worldwide to enter the vast Chinese market.

Chinese President Xi Jinping then launched China International Import Expo Bureau (CIIE) in 2018, which showcases the vast offerings of the Chinese market and serves as a platform for nations and regions to strengthen international trade and drive global economic growth.

The expo—which is strategically situated in Shanghai whose great economic strength and well-developed service industries have supported the hub for global trade— held its 7th edition from Nov. 5 to Nov. 10, 2024.

Diverse, targeted exhibitions

Alongside the exhibition of diverse industries, the expo featured events like supply-demand matchmaking sessions, seminars and product launches to support the participants. This variety of business avenues had attracted a large number of professional buyers, creating strong demand for products.

Also among the expo’s highlights was the Medical Equipment and Healthcare Products Exhibition Area which centered on the theme of “Healthy China, Better Life.” It showcased a range of offerings such as medical instruments, pharmaceuticals, nutritional and health food as well as health and elderly care; and highlighted the latest development trends and common topics in the global healthcare industry.

Exhibitors refer to innovative drugs and devices that have transitioned from being showcased at the CIIE to becoming products actively used in China as “CIIE babies.” Each year, a new batch of these “CIIE babies” is introduced to the market.

Many participants view the CIIE as an “accelerator” that drives their growth in China and also helps them expand their partnerships and collaborations with various stakeholders. Moreover, the medical area has proven its efficiency in the expo as it consistently ranks as one of the most popular exhibition zones.

Fostering cross-border collaborations

CIIE has gained the confidence of its exhibitors to serve as their essential and critical channel to connect with the Chinese market. This has built a collective effort to share opportunities with the world and subsequently shape the industry trends.

“CIIE creates a platform for us to gain a deeper understanding of global issues and trends, technological innovations, and cuttingedge science and products. On top of that, the relationships and strategic partnerships we built at this event proved to be invaluable,” said Jerry Felton, CEO of Melaleuca.

“The extended impact of the CIIE has led to our decision to build overseas regional headquarters, smart factories as well as an R&D center, and these investments will also bring a more diversified, localized

and modern consumption experience for Chinese consumers,” Xu Wei, president of Melaleuca China, likewise stated.

The expo embodies China’s openness commitment, which is demonstrated as well in the series of landmark policies the country has implemented. China has opened its doors wider by removing all market access restrictions for foreign investors in the manufacturing sector. It has also given zero-tariff treatment for 100 percent tariff lines to all the least developed countries with which it has diplomatic relations. Furthermore, it continues to build international exchange and cooperation platforms such as CIIE.

Thriving global trade ecosystem

These developments and events boost the confidence of investors in the Chinese market, ensuring that they are gearing towards a win-win outcome. On a larger perspective, it creates a thriving global trade ecosystem which benefits extend beyond China.

Be part of this pivotal event and seize the opportunity to build partnerships. Visit https://www.ciie.org/zbh/en/ to contribute to the global dialogue at the 8th CIIE.

‘CIIE creates a platform for us to gain a deeper understanding of global issues and trends, technological innovations, and cutting-edge science and products’

HOSPITAL WATCH: THE MEDICAL CITY

The Medical City eyes wider access to liver transplants

Manila has a low transplant volume due to high costs.

PHILIPPINES

The Medical City (TMC) Ortigas has partnered with state-owned Rizal Medical Center (RMC) to expand its access to liver transplants amidst the Philippines’ underdeveloped organ donation system.

Unlike many Western countries and some Asian neighbours, the Philippines has low organ donation rates, Vanessa de Villa, director of the Center for Liver Health and Transplantation at TMC Ortigas, told Healthcare Asia in an interview.

“We’ve been doing [liver transplantation] since 2011, yet we’ve only completed 26 cases,” she said. “That’s about two transplants a year.”

To address the challenge, de Villa explored the public-private partnership model, leading to TMC’s collaboration with RMC. “Since RMC is a Department of Health-affiliated hospital, securing government support would be more feasible.”

The partnership also focuses on strengthening the country’s liver transplant ecosystem through capacitybuilding initiatives, knowledge-sharing, and donation efforts.

“The centre also has a solid liver programme and has actively sent young doctors abroad for further training,” she said. “Together, we can bridge the gaps and create

We can offer highquality liver transplants, so why not provide patients with an affordable, local alternative?

a sustainable, high-quality liver transplant programme for Filipinos.”

De Villa, a general surgeon, attributed the low transplant volume to the procedure’s high costs, with most Filipino patients opting to go to countries like India or Taiwan. “The numbers in India are staggering, with hundreds of transplants performed there, whilst we have yet to reach 100.”

“Many would prefer to stay in the Philippines if given the choice, but the perception is that private hospitals are too expensive,” she said. “Those who go overseas manage to secure support from sponsors and charitable foundations," she continued.

The hospital’s Liver Center runs the most active liver transplantation programme in the country, further reinforcing the collaboration.

Transplants will begin at the Manila-based hospital whilst the programme is being developed at Rizal Medical Center. The state hospital is building another facility that de Villa hopes will provide the needed infrastructure for the transplant programme.

“I have also joined the medical staff at Rizal Medical Center, allowing me to closely observe and understand the hospital’s systems,” De Villa said. “We can offer high-quality liver transplants, so why not provide patients with an

affordable, local alternative?”

The doctor said most liver transplants at TMC involve living, not brain-dead donors.

“We have a specialised machine for cutting the liver — an ultrasonic cutter that has been an important upgrade as technology advances,” she said.

The hospital also has a dedicated liver transplant coordinator system, where specialists oversee patients’ follow-up care, medication, and potential complications. “We can provide interventional radiology, repeat surgeries, and other necessary therapies," she added.

De Villa said TMC plans to revive an initiative that seeks to create a community of transplant patients, letting them connect, share experiences, and support one another. The support group used to be active before COVID-19 struck.

“This creates a space where patients can connect,” she added.

Whilst the Liver Center itself may not have a dedicated page, The Medical City has active social media channels where patients can inquire and book consultations, a deliberate approach to streamline patient support, the hospital said.

Expansion plans

Meanwhile, The Medical City is expanding to provinces in the Philippines with at least 2 million people, according to its President and Group CEO Stuart Bennett in a separate interview.

The Manila-based hospital chain currently operates 72 primary care clinics and plans to add at least 28 more over the next two years, whilst also acquiring existing hospitals.

Bennett, who started his career as a front-line military surgeon in the UK Royal Navy, said they are targeting areas outside Metro Manila that don’t have enough hospitals, such as Cebu and Davao.

“Our approach is very simple,” he said. “We want to target the biggest threats to the Filipino population. What are the leading causes of death? What are the biggest causes of long-term illness?”

TMC’s flagship hospital in Pasig City, near the Philippine capital, has 521 beds and is set to expand by year-end. It also has branches in Clark, Pampanga Province, Laguna, and Pangasinan on the main Luzon

The hospital has only completed 26 liver transplantations since 2011

HOSPITAL WATCH: THE MEDICAL CITY

island and Iloilo province in central Philippines.

Bennett said tech innovation is critical to their expansion efforts.

“This year alone, we are purchasing a new linear accelerator for cancer treatment,” he said. “We are still finalising which machine we will acquire, but it will be state-of-theart and enhance our radiotherapy capabilities," he added.

Furthermore, the hospital established a next-generation sequencing facility that provides advanced DNA testing for cancer and prenatal screening.

TMC is also investing in the latest version of the Da Vinci robotic surgery system and exploring more ways on how artificial intelligence (AI) could enhance its clinical services.

“We have been using it for years in our chest X-ray analysis.”

“Since AI is widely discussed but not always well understood in terms of proper application, we are ensuring that we approach it thoughtfully rather than rushing into areas we are not fully familiar with,” he added.

The company is also exploring partnerships to widen its reach, the CEO said, adding that TMC works closely with the government to improve healthcare.

The hospital recently collaborated with Neural Mechanics Inc. to improve proactive health screening and provide easy access to personal health profiles through remote monitoring and predictive analytics.

TMC manages Guam Regional Medical City, though international expansion is not a priority now.

“We are also strengthening our relationships with Papua New Guinea and other small Pacific islands, aiming to build a regional healthcare network,” he added.

Clinical trial efforts

Beyond liver transplantation, The Medical City Ortigas has a multicentre clinical trial site that conducts studies across specialisations such as oncology, cardiology, hepatology, and infectious diseases.

The Medical City's Clinical and

Translational Research Institute is exploring chimeric antigen receptor (CAR) T-cell therapy, a treatment that helps the patient’s immune system better recognise and destroy cancer cells.

The institute is also involved in stem cell research and gene therapy, though these initiatives are still in their early stages, Edgar Dimaguila, Clinical Trial Unit head at TMC, said in the same exclusive interview.

“We have had initial discussions with the stem cell company,” he said. “They are also equipping us with the necessary training for the programme," he continued.

The trials conducted within The Medical City mainly come from international and multinational research and development companies, he added.

Dimaguila said The Medical City is operating at full capacity, with clinical trials underway at all five hospital branches in the Philippine capital and in the provinces of Iloilo, Pampanga, Pangasinan, and Laguna.

Edgar Dimaguila
Stuart Bennett
Treatment room
Gene sequencer and haemological analyser
Lab for chimeric antigen receptor (CAR) T-cell therapy
Non-invasive liver scans

MEDICAL FAIR THAILAND 2025: Where healthcare meets innovation and possibility

This exhibition offers unparalleled networking, sourcing, and learning opportunities, addressing the region’s rapidly growing healthcare demands.

Healthcare professionals, buyers, and industry leaders from across the globe will gather in Bangkok from 10 to 12 September 2025 for MEDICAL FAIR THAILAND 2025 — the region’s leading exhibition for medical and healthcare innovations. Organised by Messe Düsseldorf Asia, this 11th edition promises to be the largest yet, featuring over 1,000 exhibitors from more than 40 countries, presenting 10,000+ products and solutions across the healthcare value chain.

Held at BITEC, Bangkok, the three-day event provides a comprehensive platform for sourcing, networking, and learning in one of the world’s most dynamic healthcare markets. With 20 national pavilions and country groups represented — including Austria, Belgium, and Germany — attendees can expect a worldclass showcase of medical technologies, diagnostics, digital health solutions, and advanced MedTech manufacturing.

Why MEDICAL FAIR THAILAND matters

Southeast Asia’s healthcare demands are rapidly growing, fuelled by demographic shifts such as an ageing population, rising chronic diseases, and increasing healthcare investments. MEDICAL FAIR THAILAND addresses these trends directly, offering a platform that connects global innovations

with regional needs.

The exhibition spans 20,000 sqm and caters to hospital buyers, distributors, healthcare providers, and innovators seeking to explore next-generation technologies and forge crossborder partnerships. Attendees can compare solutions side-by-side, understand emerging trends, and discover innovations shaping the future of care delivery.

Spotlight on Key Zones

To ensure targeted engagement, the event features several specialised zones:

The LaunchPad Zone showcases start-ups and emerging MedTech companies. This space highlights disruptive innovations and fresh ideas from first-time exhibitors.

Meanwhile, the Community Care Zone is focused on rehabilitation, homecare, and ageing-in-place solutions. This area responds to Southeast Asia’s rising demand for patientcentric and value-based healthcare.

Lastly, the Medical Manufacturing Zone is dedicated to advanced production, automation, and supply chain solutions, reflecting Southeast Asia’s increasing role in global medical device manufacturing.

WT | WEARABLE TECHNOLOGIES CONFERENCE 2025 ASIA

Amongst the event’s highlights is the WT |

Wearable Technologies Conference Asia 2025, co-organised with MEDICAL FAIR THAILAND. This full-day conference will take place on 10 September 2025, from 10:00 am, at BITEC Bangkok, offering a deep dive into wearable technologies across healthcare, sports, and more.

From smartwatches detecting heart irregularities to wearable ECG patches enabling remote patient monitoring, wearable tech is reshaping healthcare. The conference will bring together global experts to discuss the latest developments in digital health, sports tech, remote monitoring, and telehealth.

Free for all registered visitors, the conference also offers exclusive networking opportunities with industry leaders, making it a prime platform for exploring collaborations and showcasing innovations to new audiences.

Why Register Early?

With over 12,000 healthcare professionals, buyers, and decision-makers expected to attend, early registration is highly recommended. Registered visitors will enjoy: fast-track entry to the exhibition halls; early access to the business matching app, connecting them with exhibitors and solution providers ahead of time; and timely updates on conference schedules, networking events, and exhibitor highlights

MEDICAL FAIR THAILAND

2025 is more than an exhibition

MEDICAL FAIR THAILAND 2025 is more than an exhibition—it is a strategic platform for advancing healthcare innovations, fostering partnerships, and staying informed about the latest industry developments. Whether you’re sourcing solutions, exploring collaborations, or seeking insights into future healthcare trends, this event provides the connections and knowledge to move forward.

Secure your spot. Visitor registration is now open at www.medicalfair-thailand.com. Join us this September in Bangkok and be part of the conversation shaping the future of healthcare.

Medical Fair Thailand

SPARKING DISCOVERY ELEVATING HUMANITY

advance glucose biosensing technology

Dexcom leads in advanced glucose biosensing technology, providing innovative, real-time monitoring solutions that empower individuals with diabetes to better manage their condition and improve quality of life through accurate, continuous data.

HOSPITAL WATCH: THOMSON MEDICAL CENTRE

Thomson Medical to launch second fertility hub

Thomson Medical Centre plans to launch a second fertility centre in Singapore in the latter half of 2025 amidst strong local and international demand due to changing views on family planning and improved reproductive technology.

“The upcoming Thomson Fertility Centre will allow us to serve those seeking support better,” Jack Ng, chief operating officer at Thomson Medical Group Ltd., told Healthcare Asia in an exclusive interview.

“We will explore artificial intelligence (AI) in assisted reproduction technology procedures and strengthen our existing network of fertility services,” he added.

Singapore’s family planning policy has shifted in recent decades from population control through its “Stop-at-Two” campaign to one that encourages couples to have more

children to reverse declining birth rates and promote larger families amongst financially stable couples.

The shift is often referred to as the “Have-Three-or-More (if you can afford it)” campaign that started in the year 1987.

Market challenges

The listed private hospital operator, which specialises in gynaecology and in vitro fertilisation, also offers intrauterine insemination. “There’s also elective egg freezing for women who want to take control of their fertility," according to Ng.

The group also operates Thomson Chinese Medicine clinics, which complement fertility and holistic wellness with an “east meets west approach,” Ng said.

Thomson Medical Group, which operates in Singapore, Malaysia, and Vietnam, posted a net loss of $9.5m

(S$12.6m) in the first half ended 31 December 2024, a reversal of its $3.6m (S$4.9m) net income a year earlier, its financial reports showed.

The company attributed the net loss to challenges in the Malaysian market, increased interest expenses after acquiring Far East Medical Vietnam Ltd., and the cessation of noncore transitional care facilities in Singapore.

Investing in upgrades

According to Ng, the hospital has broadened its expertise to orthopaedics, ophthalmology, and oncology. “We have also grown our ambulatory care services in tandem with the broader national healthcare agenda in Singapore.”

Earlier this year, Thomson Medical Centre performed its first wireless endoscopic decompression of the lumbar spine, a minimally invasive procedure that uses a tiny, flexible camera to treat spinal conditions.

“Plans for the latter part of the year also include clinical solutions to support cancer patients undergoing chemotherapy and surgery,” Ng said. “Our focus of diversifying medical specialities is centred around the healthcare needs of a family.”

Thomson Touch app

The hospital, which opened in Singapore in 1979, started its digital shift with the launch of the Thomson Touch app late last year.

The app streamlines patient services such as admissions, all from the convenience of patients’ smartphones. Payments and bill management can also be handled on the app.

Information such as doctor profiles and maternity bill estimates are also on the app, whilst appointmentmaking and hospital maternity tours can be booked through it, Ng said.

The COO said Thomson Medical has invested in medical hardware upgrades, particularly in its radiology department. “We have added a new MRI (magnetic resonance imaging) machine in our renovated MRI Centre, allowing us to better meet patient needs," he added.

“Completing this support network is our Thomson Fetal Assessment Unit, offering fetal diagnostic services like detailed ultrasound scans under one roof,” he added.

The facility airms to explore AI in assisted reproductive tech (Photo from Thomson Medical)
Jack Ng

KMI Healthcare is dedicated to providing comprehens ive medical solutions with an emphasis on patient-centered care. Our high ly skilled professionals and state-of-the-art facilities guarantee the highe st standards of treatment and service.

Aiming to become the "Trusted Healthcare Provider o f Choice", we are committed to gaining a deeper understanding of our patients' needs. This commitment enables us to deliver quality healthcare services tailored to the living and working environments of the community.

Experience Cutting-Edge Medical Technology at Capitol Medical Center

At Capitol Medical Center, we are committed to providing high-quality healthcare by combining excellent medical expertise with technologically advanced medical equipment

Choose Capitol Medical Center – Right Care, Right Here

Trunkline: (632) 8372-3825 | (632) 5318-5100

Mobile: +63 919 0691890 to 91

Email: info@capitolmedical.com.ph www.capitolmedical.com.ph

Scan the QR code to learn more.

Address: Quezon Avenue corner Scout Magbanua Street, Quezon City Philippines, 1103

HEALTHTECH WATCH: STORAGE SYSTEM

Sengkang Hospital taps robots to streamline surgery setups

The system delivers ready-to-use instruments directly to operating tables.

Singapore’s Sengkang General Hospital (SKH) is using robots and conveyor belts to store, retrieve, and transport delicate surgical instruments to its operating theatres, eliminating the need for manual searching and heavy lifting.

“The automated storage and retrieval system tracks inventory in real-time,” Moarie Grace Tan, assistant director for nursing and operating theatre services, told Healthcare Asia in an interview “It is controlled by computer-operated cranes and shuttles that move along the aisles to pick and deposit items in storage locations.”

Efficiency measures

The system keeps a “first in, first out” method. “Manually maintaining this process is extremely physically demanding. The system helps minimise human error,” she said.

Before, surgical instruments were stored in various places across the hospital, which made space management inefficient.

In a traditional central sterile supply department (CSSD), storage racks hold multiple sets, making it timeconsuming to find a specific one, Tan told the magazine.

“Now, it’s much easier. Staff simply tap a computer screen for the set they need, and the system automatically retrieves it,” she added.

“If a set has not gone through the proper procedures, the system automatically rejects it and flags an error,” Tan said. “Our CSSD must comply with strict health standards, including maintaining sterility and preventing cross-contamination.”

The system operates in a controlled environment, away from human traffic. “There are barricades to prevent anyone from entering the area,” she said. “With this system, there is no human interference; only robots are working.”

Tan said SKH is transitioning to a system where instruments are

Manually maintaining this process is physically demanding. The system helps minimise human error

delivered one to two hours before each surgery. “Previously, a full day of procedures in a single operating room required instruments for those surgeries to be picked and sent to the operating theatre in one batch.”

The high-tech storage system had to go through stakeholder engagement, feasibility analysis, and hardware and software development, said Jeff Tang, a senior executive at the Nursing Division, Central Supply Sterile Unit at SKH.

“The project officially began in 2022,” he said in a separate interview. “We then carried out further fine-tuning and adjustments before operationalising the system in March 2024.”

He said they have a warehouse management, listing, and tracking system that monitors inventory. “We had to synchronise all three to ensure the automated storage and retrieval system functions effectively,” he told Healthcare Asia.

“Once surgery is scheduled, the system synchronises data, allowing

the system to deliver ready-to-use instruments directly to operating tables,” he added.

Precision engineering also had to be taken into account, because even a three-millimetre variation could affect the way containers move along conveyor belts.

Striking a balance

“Even the slightest difference could cause unnecessary jittering,” Tang said. “We had to carefully strike a balance between ensuring smooth movement and preventing unnecessary damage.”

Another challenge was convincing staff, especially senior employees, that automation would ease rather than complicate their work. “After training, they have become some of the strongest advocates for the system,” he added.

SKH is also in the implementation phase for automated mobile robots (AMR) to complement the system, Tang said. “These AMRs will handle the last-mile delivery of instruments retrieved from the automated storage and retrieval system, ensuring improved distribution speed and better accuracy.”

“Looking ahead, we aim to transition from the traditional model of dispatching instruments for elective surgeries to a more efficient, case-cut model," Tan said.

The system operates in a controlled environment, away from human traffic (Photo from SKH)
Moarie Grace Tan

HEALTHTECH WATCH: VERSIUS MODULAR ROBOTIC SYSTEM

Tzu Chi Hospital treats hernias with surgical robot

The medical facility has treated 40 patients using a minimally invasive procedure.

Tzu Chi Hospital in Jakarta has launched its Hernia Center, which seeks to treat all types of hernia using cutting-edge technology, whilst promoting early detection.

Located on the hospital’s second floor, the Hernia Center offers conventional and laparoscopic hernia surgeries and includes the Versius Modular Robotic System, which is a portable surgical robot.

Developed by Cambridge-based CMR Surgical, the robot allows minimally invasive procedures, reducing tissue damage, improving patient comfort, along with speeding up recovery time.

Hernia occurs when tissue, such as part of the intestine, protrudes through a weak spot in the abdominal muscles, according to Mayo Clinic. The resulting bulge can be painful, especially when you cough, bend over or lift a heavy object, but many hernias do not cause pain, it added.

“We aim to equip our healthcare

professionals with the best tools available to ensure they can perform at their highest level,” said Satyanegara, a neurosurgeon and senior director at Tzu Chi Hospital. “This is a milestone in our journey to serve more people.”

Robots for precision

Robotic hernia surgery has proven especially beneficial in cases involving recurrent or bilateral hernias, where conventional methods may carry a higher risk of complications. The stability and precision of robotic arms allow for safer and more accurate dissection and suturing in sensitive anatomical areas.

The adoption of the advanced Versius Modular Robotic System marks a pivotal step in advancing surgical care in Indonesia.

Biomimicking the human arm, the system provides surgeons with the dexterity and accuracy of small, fully-wristed instruments and

enables them to perform operations through small incisions, which significantly reduces tissue trauma and speeds up recovery for patients.

“This robot allows us to perform complex procedures with greater control and less physical strain,” said Barlian Sutedja, a general surgeon at Tzu Chi Hospital.

“In difficult hernia cases, especially those considered complicated, robotic assistance significantly improves outcomes," he added.

The modular design allows surgeons to use only the number of robotic arms needed for a given procedure, making it small, portable, and able to fit into existing operating theatre setups.

About the hospital

The Hernia Center at Tzu Chi Hospital, which has its roots in a Taiwanese Buddhist humanitarian group, is manned by a team of surgeons who specialise in robotic technology, ensuring that each patient receives the most modern and effective care available.

The Hernia Center not only treats patients, but also trains medical professionals. Physicians can enhance their knowledge and skills in hernia management through hands-on experience with robotic surgery.

Gunawan Susanto, presidentdirector at Tzu Chi Hospital, said hernia treatment might seem straightforward, but it requires a thorough approach — from diagnostics to post-treatment care.

“We are committed to educating and guiding patients throughout the entire process,” he told reporters at the centre's 7 October launch.

Barlian noted that some patients might not even realise they have hernia. “At the Hernia Center, we offer consultations and examinations to determine if the symptoms are hernia-related, and what steps should be taken to prevent complications.”

Doctors at the Hernia Center have treated 40 patients using the surgical robot. “Robotic surgery for hernia treatment is highly effective in reducing pain, especially in complicated cases, making it an ideal choice for many patients,”

Barlian told Healthcare Asia

Doctors at the centre have treated 40 patients using the surgical robot (Photo from CMR)
INDONESIA
Satyanegara
Gunawan Susanto
Barlian Sutedja

Now helping 7 million people worldwide*

Scan to learn more about the clinical evidence of FreeStyle Libre

Easy for you2#

See your patients' complete glycaemic profiles3 with LibreView§ -a secure', cloud-based system. Make more informed treatment decisions. 3 .4

Easy for your patients2

No finger pricks', easy to apply and comfortable to wear. 2•5

Learn how food, physical activity and medications impact their glucose.

Clinically proven to improve glycaemic outcomes in T1D and T2D patients5 -7

Accurate2

No finger prick calibration.

Accurate, stable and consistent for the entire wear period, especially in the low glucose range. 8 11

References: 1. Fokkert M, et al. BMJ Open Diab Res Care. 2019;7:e000809. 2.Alva, S. et al. Diabetes Ther. 2023; doi: 10.1007/s13300-023- 01385-6. 3. Un�, J. Postgraduate Medicine (2020). https:f/doi.org/10.1080/00325481.2020.1744393. <I. Huang, E. Diabetes (2022). https:l/doi.org/10.2337/db22-73-LB. S. Haak, T. Diabetes Therapy (2017). https:f/doi.org/10.1007/s13300-016�?T�:h����i'm:

tMn�3��°Ja2����50140-6736(16)31535-5. 7. Evans, M. Diabetes Therapy(2022). https://doi.org/10.1007/s13300-022-01253-9. 8.Alva, s. J Diabetes © 2025 Abbott.ADC-112263 v1.0. The sensor housing, FreeStyle, Libre, and related brand marks are marks ofAbbott.

Asian Hospital slashes cancer treatment time with CyberKnife

The robotic radiosurgery system cuts cancer treatment from 30 to five sessions.

Manila-based Asian Hospital and Medical Center is introducing a radiotherapy technology that can track cancerous tumours in real time by adjusting to natural body movements like breathing and digestion.

The CyberKnife technology, set to launch in July, will be the first of its kind in the Philippines, Beaver Tamesis, Asian Hospital President and CEO, told Healthcare Asia. “The system is robotic and assisted by artificial intelligence,” he said in an exclusive interview.

If the tumour is in the lungs and moves as the patient breathes, or in the colon and shifts, the technology can adjust radiation delivery to minimise its impact on healthy tissues, the chief executive officer added.

Cancer was the third leading cause of death in the country in 2024, according to the local statistics agency.

Tamesis said traditional radiation techniques lack precision. For example, tumours near the eye can be risky. “A difference of just a millimetre [from the tumour] is crucial for the patient’s well-being," he said.

Conventional techniques like intensity-modulated radiation therapy need multiple sessions over several weeks, even though each session lasts only about 10 minutes. CyberKnife can cut treatment time from 30 sessions to as few as five.

“This is particularly beneficial for patients travelling from different provinces as they no longer need prolonged hospital stays,” according to Tamesis.

Investment benefits

Patient capacity is also expected to increase with the new tech, he said, noting that their old machine could only handle two patients daily. “Even that was a struggle.”

Tamesis said their tech investment was a major one, likening the cost to “‘buying a small hospital.”

However, patient costs will be covered by the Philippines’ state health insurance provider and various health maintenance organisations. “You are paying for the treatment, not the machine," he told the magazine.

The Philippine Health Insurance Corp. could cover as much as 50% of the treatment cost, Tamesis said.

The machine is being installed in the hospital’s radiation therapy bunker, which has been upgraded with enhanced air-conditioning and humidity control to ensure optimal conditions. The hospital also leverages stereotactic radiotherapy (SRT), which uses highly focused radiation beams over one to five daily fractions.

Its LINAC TomoTherapy HDA combines intensitymodulated radiation therapy with imaging capabilities from computed tomography to target tumours, delivering radiation in a “slice-by-slice” manner.

“In cases like brain tumours, where SRT or stereotactic radiosurgery is often preferred over IMRT, the TomoTherapy system can deliver the necessary precision and treatment,” Tamesis said.

“We’ve also improved facilities for infusion therapy, chemotherapy, immunologic therapy, and supportive

treatments like transfusions,” the CEO said.

Tamesis also noted that the hospital recently invested in an “all-in-one” system for tissue staining, a technique used in diagnosing diseases such as cancer, allowing for more precise and efficient tissue analysis.

“Our new equipment automates the process,” Tamesis said. “We are focusing on precision medicine. We want radiotherapy, drug therapy, and everything to align with the current movement towards personalised treatments.”

Moreover, the Philippine hospital has partnered with South Korea’s APIS Co., Ltd. to offer patients access to specialised proton and carbon ion therapy— a treatment option for resistant, recurrent, and terminal cases.

Stroke-ready hospital

Aside from cancer treatment, Asian Hospital also emphasises prompt care for stroke patients through its Brain Attack Team (BAT).

The team follows a strict protocol. “Patients who arrive within six hours of stroke onset are prioritised and directed to a fast lane on the stroke pathway.”

This is particularly beneficial for patients travelling from different provinces as they no longer need prolonged hospital stays

“Once triage activates BAT, the patient breezes through registration at the emergency room,” which is then followed by diagnostic tests,” Tamesis said.

Asian Hospital also offers Deep Brain Stimulation, where electrodes are implanted in certain brain areas to treat movement disorders such as Parkinson's disease and dystonia.

“It works by producing electric currents that affect the brain areas and certain neurochemicals that produce the symptoms,” the CEO continued.

Beaver Tamesis, president and CEO at Asian Hospital and Medical Center
PHILIPPINES

Mahkota Medical saves staff time with smart wards

The system gives nurses an extra hour and 34 minutes per patient for caregiving.

Imagine a hospital where a patient’s vital signs are monitored in real-time and alerts staff of any critical changes so they can respond in seconds. Malaysia’s Mahkota Medical Centre (MMC) is one such hospital.

“Devices used to monitor blood pressure, pulse rate and temperature are directly linked to the hospital’s system,” MMC CEO Teo Chin Yee told Healthcare Asia

Mahkota Medical Centre's smart ward system, which was developed by the hospital’s nursing informatics team and information technology experts, is also connected to electronic medical records.

“This system reduces manual entry by nurses, which not only saves time but also minimises the risk of human error,” Teo said. “This helps them spend more time on patient care. Whilst the investment in this is significantly higher, we do not charge extra so room rates remain consistent across the hospital," the MMC CEO added.

The smart wards are mainly for patients undergoing operation or radiology procedures, Teo said. Each patient has access to a bedside terminal — a tablet — to interact with the system for requests like water.

Each bed is fitted with an e-paper display that informs nurses about a patient’s condition, such as whether they are at high risk of falling or on a specific diet.

Teo, who started as a medical laboratory scientist at MMC, said this saves 37% of nurses’ time, giving them an extra hour and 34 minutes per patient for caregiving. “We also track overall experience, with 90% of patients reporting greater satisfaction in the smart ward.”

Real-time updates on matters such as discharges, procedures, and meal plans have further contributed to an increase in patient satisfaction scores.

The terminals let doctors show patients their X-rays, right at their bedside. “It also enables them to track their operation schedules,” Teo told the magazine.

“Patients have their requests addressed more quickly and access their medical records conveniently,” she said. “They are also better informed about each step of the care process during their stay hospital stay.”

Challenges in IT adoption

But the shift to integrated processes such as smart wards also has challenges, including bridging the gap between IT professionals and healthcare staff, she pointed out. “Another challenge was training our nursing team, which consisted of about 300 to 400 nurses," she noted.

The team also ensured that the programmers gained a clear understanding of processes to develop a system that genuinely supports the nurses.

“This was done through regular discussions, feedback sessions, and hands-on sessions where the programmers

This system reduces manual entry by nurses, which not only saves time but also minimises the risk of human error

observed and learned the practical aspects of nursing workflows,” Teo added.

Though most of the hospital's beds have not been converted into smart wards, the system has been installed on computers across all wards, requiring nurses from different departments to adapt.

To overcome these challenges, the centre partnered with Taiwan’s Chang Gung Memorial Hospital, which inspired MMC’s smart wards processes, Teo said. “Chang Gung Memorial Hospital has shared its expertise and provided IT experts to help us accomplish this project.”

Teo said they have also worked with MMC’s sister hospital in Johor to test the system’s adaptability. “We had to ensure the processes and programmes we designed apply to both institutions," she added.

MMC has eight wards, all of which will be fully converted into smart wards within the next 18 months.

The Malacca-based hospital’s plans to evolve into a smart facility extend beyond next-generation wards, Teo said. “We have begun work on our smart operating theatre project.”

Given the complexity of scheduling surgeries, she noted that most of it is pretty much done manually. “It mostly involves managing staff, assigning equipment, and coordinating doctor schedules.”

“At present, much of this requires manual arrangements to ensure smooth operations in the OT,” the CEO added.

“The next phase of the operating theatre project is synchronising these processes by integrating technology, automation, and data-driven systems to create a Smart OT workflow,” Teo said. “It will also integrate with our Central Sterile Services Department.

“This project should be ready within two years,” Teo said.

Teo Chin Yee, CEO at Mahkota Medical Centre
MALAYSIA

ABOUT US

King Khalid Hospital Alkharj - Saudi Arabia, is a member of Riyadh First Health Cluster under the national healthcare delivery system of the Ministry of Health, entrusted with the provision of preventive, curative and rehabilitative healthcare for the Kingdom's population. It was established over 46 years as a full service healthcare institution, certified with 350 beds and serves the people of Al-Kharj and its neighboring community. This institution aims to provide a safe environment and optimal care, services offered includes medical, surgical, critical care, cardiac care, anesthesiology, physiotherapy, rehabilitation, dental, radiological, pharmaceutical, laboratory, dietary, emergency, out-patient, home care, nursing care, primary health care, and other allied services. At present, there is a continuous effort to improve the quality of health care services as a part of KSA Vision 2030 and the National Healthcare Transformation Program aiming to improve access, quality and efficiency of care.

-Fahad Al Mamkhoor, Hospital Director-

AN AMBITION NATION A THRIVING ECONOMY A VIBRANT COMMUNITY

International:

National:

Provides

Cluster1_Riyadh

Prince Court Medical Centre taps data to cut costs and boost patient outcomes

The Kuala Lumpur-based hospital explores cost-effective alternative treatments.

Malaysia’s Prince Court Medical Centre is tracking key metrics like recovery times and patient feedback to improve service across departments, as it tries to improve health outcomes and potentially lower healthcare costs, its chief executive said.

The goal of benchmarking is not to “name and shame” but to present data objectively to clinicians and staff, Prince Court Medical Centre CEO Shuba Srinivasan told Charlton Media Group Editor-in-Chief Tim Charlton in a fireside chat at the 2025 Healthcare Asia Summit in Kuala Lumpur on 9 April.

“We also look at cost,” she said. “If we can report great outcomes with less costs, like affordable implants or stents, we encourage our clinicians to consider alternative approaches.”

“Prince Court has a committed set of clinicians with open minds. Yes, they will question and challenge me, but they are always open to change,” she added.

Here is the excerpt of the interview.

What data points are you currently looking at, and what system do you use for a predictive patient outlook?

We monitor very specific parameters. For example, if we’re looking at a procedure like a total knee replacement, we assess the length of stay and the reasons it may have been extended. If we’re looking at an ICU patient, we consider when the antibiotic was changed. When was the culture ready, and was the right antibiotic given? This kind of data helps with antimicrobial stewardship. It also helps us monitor intubation and extubation times, and readmission rates. These factors are all valuable when conducting predictive analysis using the artificial intelligence (AI) tools we have.

In terms of practical outcomes, how is it applied? When you have a standard process in place, you’re definitely able to execute it much better. For example, in the past, even cataract patients would be admitted for a day, but now we’re moving towards more procedures being done as day cases.

We’re exploring how these can be done as day procedures, but we’re not overly bullish about it. We want to get patients’ feedback, so we use patient-reported outcome measures to understand whether they’re comfortable with the changes we’re making. Most of the time, they’re quite happy with it.

Could you share the hospital’s digital transformation journey and some of its key milestones?

To start with, we were one of the first private hospitals to embark on an electronic medical record (EMR) system, and we are exploring ways to use it more effectively. In addition to this, we’ve implemented a critical care system that integrates with the EMR. These help us detect early warning signs and, importantly, allow us to review the data when suboptimal care has occurred so we can continuously improve.

We’re also exploring how artificial intelligence can assist in imaging—how it can interpret scans more accurately and help us become more precise.

What upskilling is taking place at Prince Court to manage change and ensure seamless collaboration between tech and healthcare professionals?

Change is never easy, but how do we communicate it? How do we explain that AI is a tool that enhances and supports our workforce? No one can replace what we do for our patients, but it helps us manage things more efficiently.

For example, in hospitals, we often have verbal orders that nurses transcribe. Sometimes, things get lost in translation, which leads to medication errors. What we’re looking at now is artificial intelligence with voice integration into electronic medical records, so instructions are transcribed automatically. Once the instruction is accurately captured, we can deliver care in the right way.

These help us detect early warning signs and allow us to review the data when suboptimal care has occurred so we can continuously improve

Early warning systems are also incredibly important. Beyond that, we are exploring how predictive analytics can help determine the right parameters for extubating a patient or identifying the optimal time for discharge. This can reduce the risk of readmission, return to the ICU, or reintubation.

What key insights has Prince Court gained through crossborder collaborations?

Prince Court is fortunate, as around 25% of our patients are non-Malaysians. We are constantly learning how dynamic healthcare can be. For instance, we ask ourselves which procedures can be done on an outpatient basis and how we can leverage telemedicine for post-care. We also explore how to conduct follow-up calls to gather patient-reported outcomes and feedback.

Shuba Srinivasan, Prince Court Medical Centre CEO
MALAYSIA

UTAR Hospital pushes specialist rural care

CEO Ding Lay Ming wants to reach the poor whilst also serving those who can pay.

Specialist healthcare remains out of reach for many Malaysians in the countryside due to distance and infrastructure gaps. The CEO of Universiti Tunku Abdul Rahman (UTAR) Hospital is trying to bridge those gaps.

Upgrading the facility’s services requires a focus on the five M’s of management — machines, manpower, money, materials, and methods, Ding Lay Ming, CEO at UTAR Hospital, told Healthcare Asia

Officiated by the Sultan of Perak last February, the hospital is in Kampar, Perak — an area once known for tin mining but is now sparsely populated compared with Malaysia’s urban centres. As a result, it lacks access to specialist healthcare available in major cities.

“Malaysia has a strong healthcare system nationwide. However, when it comes to specialist services, there are gaps in availability,” Ding said in an exclusive interview with the publication. “We want to bridge this gap for those who have to travel long distances for treatment.”

“Once secondary care is in place, we will focus on expanding the hospital’s tertiary care,” she added.

Plans for growth

As a ‘not-for-profit’ medical institution, the hospital’s $67.9m (RM300m) initial cost was funded through tree planting, charity concerts, dinners, and support from various organisations and philanthropists.

Ding said becoming self-sustaining is a necessity, though it would take time. “[The hospital] is still in its early stages,” she said. “But we will ensure we reach the less fortunate whilst providing services to those who can pay.”

UTAR Hospital plans to acquire a positron emission tomography (PET) scan, a medical imaging device that utilises radioactive substances to measure metabolic processes in the body to assess cancer, neurological, and cardiovascular diseases.

It is also setting up a nuclear medicine unit, whilst services for ear, nose, and throat (ENT), cardiology, and eye care are expected to be operational within the year, Ding told the magazine.

Also in the pipeline is a cath lab, where doctors perform minimally invasive tests and procedures to diagnose and treat cardiovascular conditions.

Ding, a retired Perak state health director, said sustainability lies in pioneering systems that could evolve, improve, and adapt. “People come and go, but systems remain.”

However, artificial intelligence (AI) integration is not a priority, she pointed out. “As much as I like AI, it cannot build relationships in the same way humans do.”

“Throughout my career, I have been deeply involved in quality initiatives,” she said. “A coordinated, systematic approach to quality improvement can significantly enhance

efficiency and improve patient outcomes.”

The hospital, which plans to pursue medical research, will establish an ethics and research committee to regulate such activities, according to the CEO.

“Since this is a new hospital, we are establishing the necessary work processes to ensure that our clinicians have access to up-to-date knowledge and relevant medical journals,” she told the magazine.

Clinical trials will follow in time, Ding pointed out.”Once we have a larger patient pool and clinicians who are actively engaged in specific areas of research, we will be able to recruit patients for clinical trials.”

“If contract research organisations or companies approach us, we will assess whether our clinicians are ready to participate,” she said. “However, at this stage, setting up the legal framework and other required processes is still a work in progress.”

UTAR Hospital integrates Western medicine and traditional and complementary medicine — a model that offers alternative treatments such as acupuncture and Ayurvedic therapies, alongside conventional medical care.

“A dedicated traditional and complementary medicine facility operates alongside the hospital, linked by a bridge," according to the UTAR Hospital CEO.

The integrated model is particularly beneficial for Malaysia’s ageing population, she said. “When they come for traditional and complementary medicine, they may also need Western medical treatment. Our setup ensures they complement each other," she told Healthcare Asia

People come and go, but systems remain
Ding Lay Ming, CEO at UTAR Hospital
MALAYSIA

Chiayi Chang Gung Memorial Hospital

Chiayi Chang Gung Memorial Hospital From Crisis to Clinical Breakthrough Life-Saving Results

Chiayi Chang Gung Memorial Hospital

Awarded the ESG Program of the Year – Taiwan, Chiayi Chang Gung leads in promoting fasciitis prevention in coastal areas
Chiayi Chang Gung Memorial Hospital National Recognition for Medical Excellence Taiwan’s Pride
Chiayi Chang Gung Memorial Hospital
Seamless Collaboration, Swift Action Innovative Team Care

CASE STUDY: TAN TOCK SENG HOSPITAL

Tan Tock Seng Hospital pilots sleep apnoea treatment

It combines expertise from ENT, psychiatry, and respiratory medicine.

Snoring, often dismissed as a harmless quirk of sleep-deprived people, may signal a bigger problem. Singapore's Tan Tock Seng Hospital (TTSH), a healthcare institution of the National Healthcare Group, is addressing this concern with the Integrated Sleep Service. Sleep apnoea, a disorder characterised by breathing interruptions, remains largely underdiagnosed in Singapore, Dr Lee Chuen Peng, a TTSH Respiratory and Critical Care specialist, told Healthcare Asia. “This can lead to further medical problems.”

Singaporeans are the most sleepdeprived amongst 17 markets, with 54% getting less than the recommended seven hours of sleep daily, according to a YouGov survey released in 2023.

According to Lee, the city-state is gradually building its capabilities in sleep medicine, and TTSH’s Integrated Sleep Service, which is still in its pilot phase, refers patients to a pool of trained general sleep

practitioners at the hospital. These include respiratory physicians, neurologists, psychiatrists, ENT specialists, and family practitioners.

CPAP therapy

In line with this, TTSH, Singapore’s second-largest acute care general hospital, offers in-house continuous positive airway pressure (CPAP) therapy, which Lee described as ‘the golden standard.’ “Most patients, who tested positive for sleep apnoea with a home sleep study, will be started on CPAP as an initial form of therapy.”

“They go through a session where we help them select a mask. We then loan the device for a month-long trial period,” he added.

Addressing these gaps will be essential to improving early diagnosis and treatment of sleep disorders

At the end of the trial, the CPAP device is returned and the data is analysed to assess the treatment’s effectiveness.“More than 50% of patients typically choose to continue using CPAP as their main form of therapy," he told the magazine.

The patient is then referred to the device vendor, though they need to

return to Tan Tock Seng for follow-up appointments, he noted.

If needed, a more complicated sleep study, known as a polysomnography, is conducted before presenting the patient with more management options. “Complicated cases may be referred to speciality services at the sleep centre," Lee said.

TTSH categorises sleep studies into four levels to ensure patients get tailored care. For instance, Level 2 studies can benefit stroke patients, a group where obstructive sleep apnoea prevalence reaches 70%, Lee, a pulmonologist and intensivist who also practises sleep medicine, said.

Some of the level 2 studies are usually conducted at the hospital’s Integrated Care Hub where most patients undergo ambulatory rehabilitation. Sleep technologists utilise portable testing equipment at their bedside.

Lee said these sleep studies could take a lot of work, adding that complex cases could take as long as two hours. “We need to examine every 30-second interval of sleep on a page-by-page basis.”

The hospital is looking at how artificial intelligence (AI) could help analyse sleep recordings to automatically detect sleep stages. “Eventually, we aim to incorporate AI into the sleep laboratory processes,” Lee told the magazine.

Other initiatives

The hospital has also launched initiatives, such as the Sleeptight Study, which seeks to improve sleep in patients in critical care settings.

“We have conducted studies using ‘sleep well bundle’ interventions,” Lee said. “These include reducing noise levels, ensuring appropriate lighting, enhancing comfort, promoting natural sleep cycles, and implementing patient-centred approaches," he added.

“Specifically, we are exploring how much money we can save as a nation by preventing complications associated with sleep apnoea, such as heart attacks and strokes."

Lee said awareness is lacking amongst Singaporean citizens and even doctors. “Addressing these gaps will be essential to improving early diagnosis and treatment of sleep disorders," he said.

Patients are fitted with a CPAP mask, which is then loaned for a month-long trial period (Photo from TTSH)
SINGAPORE
Dr Lee Chuen Peng

CASE STUDY: SINGHEALTH

SingHealth and Philips launch smart ICUs that minimise false alarms

The system uses predictive capabilities for early treatment in general wards.

SINGAPORE

The Singapore Health Services (SingHealth) and Royal Philips are working on optimising smart intensive care unit (ICU) capacity across the city-state’s public cluster to prevent frequent false alarms that can overshadow real emergencies and put patient safety at risk.

“Predictive capabilities integrated into the system can detect patient deterioration early and allow treatments to be given in the general ward without having to move patients to the ICU,” Nic Schneider, head of hospital and patient monitoring at Philips Asia-Pacific, told Healthcare Asia.

“The system connects data across departments and varying levels of patient severity, where we optimise surveillance to minimise alarm fatigue,” he said in an interview.

The global ICU monitoring market is expected to grow 8.5% annually to approximately $8b by 2030 from 2023 due to the rising prevalence of life-threatening health conditions and a growing emphasis on patient safety and care quality, a report by Verified Market Reports revealed.

Expanding capacity

However, Singapore's health infrastructure development was set back by the COVID-19 pandemic, as average hospital stays rose to seven from six days, or a 15% increase in workload, Health Minister Ong Ye Kung said in a speech at the Ministry of Health Committee of Supply Debate 2025. “Expanding capacity does not mean just building hospitals,” Ong said. “We need smart capacity, across a spectrum of care needs and, especially, in the community.”

With rising demand for critical care, hospitals often experience a shortage of beds and experienced clinical staff in areas like the ICU, Schneider said. “60% of healthcare

leaders in Singapore reported delays in care due to staff shortages.”

A majority (84%) said they faced problems with data integration in their organisation, which can make it harder to provide timely, high-quality care and may affect patient outcomes.

Early warning scores, custom algorithms, and clear data displays will be implemented to reduce staff workload. “This allows for quick and accurate recall of vital sign information," he said.

Royal Philips would also help SingHealth, Singapore’s biggest public healthcare cluster, develop artificial intelligence (AI)-powered models and algorithms to monitor developments in patients’ conditions and optimise alarm management, he told the magazine.

Both organisations signed a memorandum of understanding last February, outlining three key projects over three years that focus on integrating imaging data with artificial intelligence, predictive data management, and optimising intensive care unit capacity.

The infrastructure will be designed

to work seamlessly across systems, meet cloud and cybersecurity standards, and support clinical workflows, Schneider said.

Project rollout

The project rollout will be phased in consultation with key stakeholders, said Lawrence Loke, group chief information officer at SingHealth.

“As with all projects, successful implementation hinges on effective change management, seamless integration, and stakeholder engagement,” Loke said in a separate interview. SingHealth would also prioritise early staff engagement during the planning process, along with training programmes to ensure a smooth transition, he added.

Philips will roll out its healthcare transformation services to SingHealth institutions, offering strategic consulting and hands-on training. “The scope is centred on these projects,” Loke said.

“However, we remain open to future opportunities for collaboration where there is shared interest and strategic alignment," he continued.

Royal Philips would also help SingHealth develop AI-powered models (Photo from Royal Philips)
Nic Schneider
Lawrence Loke

COUNTRY REPORT: PHILIPPINES

Private hospitals told to avoid reckless spending

Healthcare claims could increase by 21% this year, the highest in Asia.

Philippine private hospitals should cut costs by avoiding wasteful spending, including on medical supplies, to ease the burden on patients, as personal healthcare claims in the country could rise by 21% this year — the highest in Asia.

“We analyse each procedure’s actual cost to remove unnecessary expenses and implement a just-intime inventory system to reduce waste in medical supplies,” Beaver Tamesis, CEO at Asian Hospital and Medical Center, told Healthcare Asia. Private hospitals should also start offering affordable medical packages for procedures such as gallstone removal and pneumonia treatment, instead of catering only to the rich, he said in an exclusive interview.

Whilst the cost of medical claims across Asia is expected to stabilise this year, the Philippines is expected to experience a 21% increase in healthcare claims — the highest in Asia, where the average rate is placed at 13%, according to a Mercer Marsh Benefits report. The so-called medical trend rate in the Philippines was also estimated at 21% last year after rising 24% in 2023.

Rising medical claim costs

Rising costs associated with advanced treatments and an overall increase in healthcare service prices are driving the increase, said Vicky Ongchangco, Mercer Marsh Benefits’ Philippine advisory leader.

“For instance, 80% of Asia insurers reported an increase in the incidence of cancer treatment claims,” she said in a separate interview. “There is also an increased volume of utilisation and a shift towards higher-cost treatments and medications.”

A shortage of health workers is also driving the rise in claims as more Filipino professionals work overseas for better pay. “This situation is compounded by a significant increase in medical fees and salaries, which have risen by approximately 25% as set by professional healthcare organisations,” Ongchangco said.

“As private hospitals raise their prices to cope with rising medical claim costs, employers may face higher premiums for health insurance plans as insurers will likely pass on the increase,” she added.

Medical inflation

Tamesis said hospital operational costs remain high due to sterilisation protocols, infection control, and equipment. “Medicine costs also increase due to importation and research and development expenses.”

“Medical inflation is always high — it’s even double compared with standard inflation,” he added. Mercer Marsh projects Philippine inflation this year at 3%.

“There is a growing need for more accessible outpatient services,” according to Tamesis. “Specialised treatments like outpatient antibiotic therapy can help prevent unnecessary hospital admissions.”

Tamesis, who is an internist and cardiologist, said partnerships with

health maintenance organisations to enhance insurance coverage could help address the problem.

Allocating Philippine Health Insurance Corp. beds ensures that even government-supported insurance could be used in private settings, he added.

The insurance industry is stepping up to address the financial burden, said Nandy Villar, AXA Philippines chief marketing officer. “We have a critical illness product that offers extensive protection, covering over 150 conditions across different stages,” he told the magazine.

Public-private partnerships, capacity-building programmes, and telemedicine integration in medical education are also expected to ease the strain. “Efficient claims processing can also contribute to financial sustainability,” he added.

Meanwhile, private equity investments aimed at expanding and upgrading hospitals were on the rise. “There was a growing focus on specialised care fields such as cancer treatment and diagnostic imaging.”

“Treatment advancements are good for care, but they tend to be expensive,” Villar said. “These are realities hospitals and insurers must continuously navigate.”

Medical fees and salaries have risen by about 25% as set by healthcare organisations
Vicky Ongchangco
Beaver Tamesis

REGION REPORT: HONG KONG

Hong Kong seeks prescription for nursing shortage

The city faces a shortfall of over 8,000 nurses.

Hong Kong should offer a more attractive compensation package to nurses amidst stiff global competition for healthcare professionals, many of whom are enticed to work in countries that offer better pay and a lighter workload.

Simply standing by is not an option, especially when the region is facing a persistent shortage of nurses, Hong Kong Health Secretary Lo Chungmau told Healthcare Asia

“Despite increasing nursing training places from about 2,900 in 2017/2018 to 4,500 in 2023/2024, we still face a shortfall of over 8,000 nurses,” Lo said. “We need to be realistic and face the keen global competition head-on.”

Factors behind shortage

This shortage is worsened by nurses seeking better opportunities outside Hong Kong amidst high workloads and burnout, said Shin Thant Aung, director at YCP's Thailand office.

“For example, nurses from Indonesia and India are trying to work in Malaysia, and Malaysian nurses in Singapore or Hong Kong,” he said. “Similarly, Hong Kong nurses are aiming to work in the US, UK, or Australia.”

As of March this year, the monthly salary of registered nurses in Hong Kong ranges from

$36,570 to $58,843, according to the Hospital Authority (HA).

“To compete globally, Hong Kong must improve working conditions, offer competitive salaries, and create stronger support systems for nurses,” Aung told the magazine.

The Hong Kong Legislative Council recently passed a bill allowing non-locally trained nurses to practise in the city without taking the local licensing exam.

The city is also bolstering the recruitment of nurses from nearby countries like Malaysia and Macau “provided they meet the rigorous professional qualification and competency requirements set by the Nursing Council of Hong Kong,” Lo told the magazine.

“We must attract the best nurses to come and practice,” he added.

These initiatives are not only expected to ease work pressure and burnout but also bring diversity into the workforce, according to Rathanesh Ramasundram, director for Healthcare and Life Sciences at Frost & Sullivan.

“Hong Kong will likely become a more multicultural healthcare hub,” she said. She added that more foreign nurses mean more competition, which could both be a cause for concern and an opportunity for local nursing graduates.

“Local nurses may feel there are

fewer job opportunities or slower career progression,” she said. “The situation also presents the chance to enhance professional growth through pursuing specialisations and certifications to remain competitive.”

Facing barriers

However, foreign nurses still face challenges related to cultural adaptation, language barriers, regulatory compliance, team integration, and the need for ongoing support, Ramasundram said.

She said recruiting foreign nurses might not be sustainable in the long run. “An overreliance on non-locally trained nurses could delay structural reforms in Hong Kong’s healthcare workforce planning.”

“Filling the increasing requirement of nurses with non-locals will incur rising costs of recruitment and overdependence on non-local resources,” she added.

Aung warned that relying too much on foreign nurses could worsen the loss of local talent, forcing more nurses to seek job opportunities overseas. “This is not sustainable, as it comes with a range of difficulties, including economic and social implications," he said.

“Locally trained nurses may feel demotivated by perceived favouritism, especially if career progression or job opportunities appear skewed,” Ramasundram added.

Lo said the government policy prioritises the employment of locally trained nurses. “The new admission pathways for nurses are designed specifically in this spirit.”

“For non-local nurses to practice in Hong Kong, they must first secure employment from institutions such as the HA and the Department of Health,” he said. “These institutions are duty-bound to accord priority to employing locally trained nurses.”

He also said the Hospital Authority has implemented a preceptorship programme, appointing experienced nurses to supervise recruits and help them become familiar with ward procedures and the work environment.

“The Department of Health will also organise orientations, induction training, and peer support schemes,” Lo said. “With more nurses to share the workload, local nurses could dedicate more time and attention to caring for patients.”

The monthly salary of nurses in Hong Kong ranges from $36,570 to $58,843
Shin Thant Aung
Rathanesh Ramasundram
Lo Chung-mau

Gleneagles Johor cuts waiting time with real-time patient tracking

Its command centre can forecast how many patients are expected to be discharged.

Gleneagles Hospital Johor has reduced patient waiting times to as little as one-anda-half hours through its Central Resource Center (CRC), a command facility that predicts and monitors admissions and discharges in real time, according to its CEO.

“It can tell us how many patients are likely to leave on a given day— even before doctors make the official decision,” Gleneagles CEO Kamal Amzan told the Healthcare Asia Summit 2025 attendees in Kuala Lumpur on 9 April.

“Thanks to its artificial intelligence, the centre can forecast discharge volumes—so we know, even in advance, how many patients are expected to be discharged each day of the week,” Amzan added.

Before, patient admission and discharge took about three hours each, which reduced bed turnover and satisfaction, he pointed out. “I asked the team to look into how long it takes for the patient to be admitted and how long it takes for them to be discharged. Almost half of the complaints we had were about waiting time," he continued.

“After the intervention, the admission time dropped to about one hour or less. Meanwhile, discharge time has been maintained at around one-and-a-half hours,” he added.

Patient mapping

The centre allows the hospital team to track down patients, whether they are in the emergency department, lobby, or even in a taxi, the CEO, a public health expert, said.

“If a patient is still in the room an hour after discharge, they’ll follow up to ensure the patient is on their way home,” Kamal said. “Meanwhile, if the room hasn’t been cleaned within 30 minutes, they’ll speed up the housekeeping team.”

A detailed mapping of patient workflows showed more than 125 discrete activities across eight departments that contributed to admission delays. ”We were able to

reduce the number to 72.”

Gleneagles then launched a pre-admission registration system, particularly for patients scheduled for nonemergency admissions. “They just need to sign a few documents at the hospital then we bring them straight to the ward.”

“There’s no queue or registration at the front desk,” Kamal said. “We’ve removed that step entirely. We were able to cut down the time spent on routine processes from 39 minutes to to 24," he told the attendees.

Market

for electronic health records

Meanwhile, similar improvements were also implemented in Gleneagles’ emergency admissions and discharge process.

Management operating blueprint

The CEO also introduced a management operating blueprint, which he described as a customised version of the plan-do-study-act cycle. “This takes a whole-of-hospital approach, not just involving the business office or nursing, but also incorporating human capital.”

We were able to cut down the time spent on routine processes from 39 minutes to 24

Globally, the patient registry software market size is expected to grow 12.53% annually to $3.49b by 2030 from 2025 due to the rising adoption of electronic health records and the growing use of patient registry data for postmarketing surveillance, according to a Mordor Intelligence report.

Industry players worldwide are searching for innovative, affordable ways to deliver tech-enabled, patientfocused care both in and out of hospitals, it pointed out.

“The focus is now on departmental performance rather than individual performance, and even the CEO is directly involved,” he said.

“The blueprint is structured around daily, weekly, monthly, and annual performance reports, ensuring that everyone is accountable and responsible for their respective tasks at each level,” Kamal said.

Before, a single supervisor or manager was responsible for a large team, but now, the hospital has each supervisor overseeing up to three staff members, he added.

Kamal Amzan, CEO at Gleaneagles Hospital Johor
MALAYSIA

www.bangkokhospital-chiangmai.com

EVENT NEWS: HEALTHCARE ASIA SUMMIT

How patient-focused care reduces costs and improves outcomes

The approach can also improve patients' adherence to treatment by 60%.

Adeep understanding of a patient’s personal and living circumstances will not only improve care but also cut costs, according to a Frost & Sullivan executive.

“Patient-centric care has been shown to reduce healthcare costs by 93% and improve patient adherence to treatment by 60%,” Sowmya Srinath, director of healthcare and life sciences at Frost & Sullivan, told the Healthcare Asia Summit 2025 in Kuala Lumpur in April.

It could also enhance health outcomes by 40% when hospital staff focus on individual patient needs and preferences, she pointed out.

Chan Si Yan, head of operations at Sunway TCM Centre in Petaling District in Selangor, said they incorporate traditional and complementary medicine into Western healthcare to provide leading-edge clinical practice.

“What we do is not just a coexistence of the systems, but an integration of both to help us [offer] the best care,” she told the forum.

Shaiful Azmi Yahaya, a senior consultant cardiologist and chief clinical officer at the Institut Jantung Negara Sdn Bhd, Malaysia’s biggest heart hospital, said patient-centric care means giving patients eligible for free

What we do is not just a coexistence of the systems, but an integration of both to help us offer the best care

care the same high-quality treatment that private patients get.

“For patient-centric care to succeed, governments need to create policies that support patient access to care and ensure the affordability of services,” he told the summit.

Subsidised

medicines

For instance, India plans to fully exempt 36 lifesaving drugs and medicines used for treating cancer, rare diseases, and chronic conditions from basic customs duty (BCD).

The announcement was made by Union Minister of Finance and Corporate Affairs Smt. Nirmala Sitharaman during her presentation of the Union Budget 2025 to 2026 in the Parliament of India.

Meanwhile, the budget proposes to exempt an additional 37 medicines, along with 13 new drugs under the 'Patient Assistance Programmes,' from BCD if supplied free to patients.

Darshinia Ballasingam, head of medical services at Assunta Hospital in Selangor, said they serve these communities, where people earn less than $126 (RM538) a month, through community services.

“These services offer inclusive care, including free home care and palliative services for children in the community,” she said.

In Australia, the government is investing an additional $1.8m (A$2.8m) for paediatric palliative care and end-of-life care services across New South Wales. Twelve local health districts and specialist health networks have received additional funding to strengthen specialist care and improve physical spaces.

Planned improvements include the creation of multi-functional, homelike spaces, bereavement support, maternity services, and post-death care. These areas will also cater to children with chronic and complex medical needs.

In addition, Ballasingam said the investment will cover cosmetic upgrades, refurbishments, and general maintenance of special care nurseries, paediatric wards, and associated facilities.

She added that the hospital provides social welfare services, offering medical care to those who need secondary or tertiary treatment.

“Patients can meet medical officers and be referred to our consultants for free, along with services like computed tomography scans and magnetic resonance imaging sponsored by Assunta Hospital,” she said.

Community care

Ballasingam said the hospital also provides emotional and social support by helping patients access social benefits or apply for assistance.

Yahaya said using a system that allows medicines to be delivered directly to patients' homes is another form of patient-centric care. This has helped save not only time but also lives, he added.

The integrated patient care systems market is projected to hit $41.8b by 2030 at a compound annual growth rate of almost 12%, said Research and Markets.

Hospitals and health systems are the primary adopters of these platforms, particularly as they shift towards accountable care models and riskbased reimbursement structures.

Institut Jantung Negara's Shaiful Azmi Yahaya urges governments to create affordable care policies

EVENT NEWS: HEALTHCARE ASIA SUMMIT

Bangkok Hospital Pattaya app flags heart risk fast

Doctors act on the warning signs before a crisis erupts.

Bangkok Hospital Pattaya is treating heart disease early in its stage using an appintegrated health assessment tool that identifies a patient’s 10-year risk in under a minute, its chief information officer said.

“Once a patient finishes the health assessment, their information is available on our BPH Connect app,” Adjariya Ezor, chief information officer at Bangkok Hospital Pattaya and Jomtien Hospital, told the Healthcare Asia Summit 2025 in Kuala Lumpur on 9 April.

“If results show high risks, our platform alerts a cardiologist, books a virtual consult, and schedules a lab test all before they feel a single symptom,” she pointed out.

Colour-coded dashboard

The BPH Connect app, called a “digital nervous system” by the biggest tertiary referral hospital on the Eastern Seaboard of Thailand, features a dashboard that classifies patient health risk scores using a colour-coded system—green for low risk, yellow for moderate, and red for high.

Artificial intelligence (AI)-driven adaptive cardiac devices are set to improve patient outcomes by enabling real-time monitoring and dynamic therapy adjustments, according to a GlobalData report.

“AI-enhanced solutions exemplify the industry’s shift toward precision medicine, aligning with regulatory bodies like the FDA,” said Cynthia Stinchcombe, medical devices analyst at GlobalData.

These devices enable a personalised approach that aligns with a patient’s changing condition, offering roundthe-clock intervention.

Stinchcombe added that the cardiovascular devices market is experiencing rapid expansion and diversification. The sector is projected to grow 5.20% annually from 2023 to reach $140b by 2033.

“At a glance, nurses can identify who needs urgent cardiology support

At a glance, nurses can identify who needs urgent cardiology support or who needs lifestyle intervention

or who needs lifestyle intervention,” she said. “Because we’ve integrated this system with our EMR (electronic medical record), high-risk alerts are triggered automatically.”

The Chonburi-based hospital’s heart disease risk tool, which factors in cholesterol levels, can be 92% accurate, Ezor told the summit audience. “This isn’t just a calculator; it’s a lifeline.”

“Initially, we focused on heart, brain, and bone health. We later expanded to other areas, including child development and elderly care screening,” she added.

Value-based care model

Ezor said the organisation started a value-based care model that seeks to increase life expectancy to more than 85 years in 2023, after the COVID-19 pandemic. “We call this our ‘mission to the moon,'" she continued.

A screening prototype test on hospital staff showed that almost 80% were at high risk of a heart attack due to high levels of bad cholesterol. “That’s why we’re investing in screening models.”

“From dementia screening to joint health scores, we’ve built Thailand’s most comprehensive risk-assessment suite validated by partners such as the American College of Cardiology,” Ezor told the summit attendees.

But tools alone aren’t enough, which led Bangkok Hospital Pattaya to create

the app, which quickly alerts doctors to health risks so they can treat the most urgent cases first.

Meanwhile, the Thai hospital also conducts school-based mental health screenings, where it found that over 75% of young people with depression go untreated. “We’ve also extended our assessments to large companies near Pattaya City," she added.

Moreover, its Heart Center features a multidisciplinary team consisting of cardiologists, interventionalists, and cardiovascular technologists who provide outpatient consultations, minimally invasive procedures, valve surgeries, and rehabilitation programmes.

“This is the future of medicine,” Ezor said. “We do not wait for a crisis—we act on the warning signs in time," she continued.

At the heart of the network, Bangkok Hospital Headquarters is also piloting new ways to make screening faster and smarter.

In partnership with Access Company Limited, the Thai hospital recently introduced an AI-powered mirror that scans a user’s face to assess vital signs and wellness indicators in just 45 seconds.

The device measures heart rate, blood pressure, oxygen saturation, and respiratory rate. It also allows atrial fibrillation screening and stress index—offering a glimpse into how everyday tools could become frontline health monitors.

The hospital has also signed a memorandum of understanding with Japan’s Tokushukai Medical Corporation to collaborate in the fields of medical services and human resource development.

Adjariya Ezor, chief information officer at Bangkok Hospital Pattaya and Jomtien Hospital

The Beekeeper

Rest, Recovery, & Rediscovery

Personalized Treatment Expert Care

Secluded Environments

Experience unparalleled recovery at The Beekeeper, with locations in serene Thailand and tranquil Sri Lanka.

What We Treat

At The Beekeeper, we treat mental health issues such as anxiety, trauma, and mood disorders, along with addiction to substances such as drugs, alcohol, gambling, and sex. We also provide expert care for co-occurring disorders with psychiatric support.

Our Integrative Approach

Our integrative approach blends expert care from clinical psychologists, psychiatrists, nurses, and other practitioners, combining comprehensive assessment, trauma-informed therapy, and eclectic techniques with supportive practices like yoga, meditation, and massage to ensure a holistic and effective recovery.

Take the first step toward a brighter future at The Beekeeper. Contact us today for more information.

Philippines’ Largest PPP Hospital Opens: A Game-Changer in Healthcare Access

The country’s healthcare landscape reaches a pivotal milestone as Makati Life Medical Center (MLMC) fully opens its doors in the heart of the country’s key Business District. Touted as the first and largest Public-Private Partnership (PPP) hospital project in the Philippines, Makati Life redefines what it means to deliver accessible, future-ready, and inclusive care, setting a new benchmark in healthcare delivery.

A collaboration between the City Government of Makati and Life Nurture Inc., Makati Life is a model of how the private sector’s expertise and innovation, when combined with the public sector’s influence and reach, can dramatically improve health outcomes, expand access, and rebuild trust in the healthcare system.

“Today marks more than an opening— it’s the beginning of a shared vision where healthcare is a right, not a privilege,” said Dr. Dennis Sta. Ana, President and CEO of Makati Life Medical Center. “Built on the power of public-private partnership, Makati Life stands as a private institution with a public heart—ready to serve all patient types across all sectors of society.”

This next phase of operations activates key hospital services including Emergency Care, Critical Care, Surgical Services, Admissions, Women’s Health. These together with its existing ancillary services are also now made available through inpatient care. In the coming months, Makati Life will open its specialty centers and advanced programs, expanding the hospital’s

footprint in subspecialty care and complex case management.

At present, Makati Life’s Outpatient Department serves up to 800 patients daily for consultations and diagnostics across Family Medicine and multiple specialties. With the launch of inpatient services, the hospital can now accommodate up to 100 patient admissions daily, with infrastructure and personnel ready to scale further.

Beyond clinical excellence, Makati Life champions a flagship Human Experience Program—placing the dignity, emotions, and needs of every patient and healthcare worker at the center of its service model. From digitally streamlined systems to personalized care journeys, every touchpoint is designed for ease, empathy, and empowerment.

In recognition of its integrated, patient-centric approach, Makati Life Medical Center was recently awarded the 2025 “Integrated Healthcare Provider of the Year – Philippines” at the prestigious Healthcare Asia Awards in Kuala Lumpur. This accolade reinforces the hospital’s commitment to continuous innovation and its role in shaping the future of healthcare delivery in the region.

“When we first dreamed of Makati Life, we weren’t just planning another hospital. We reimagined what is possible when government purpose meets private sector agility.” said

Honorable Mar-len Abigail S. Binay. “When compassion meets innovation. When we refuse to accept that any Filipino deserves less than first-class care.”

As Makati Life moves forward, it calls on partners, healthcare providers, and communities to be part of a movement that brings better care to life—delivered with expertise, compassion, and purpose.

To learn more about Makati Life Medical Center, visit www.makatilife.com or contact marketing@makatilife.com.

About Makati Life Medical Center

Makati Life Medical Center is a nextgeneration healthcare facility built through the Public-Private Partnership (PPP) between the City Government of Makati and Life Nurture Inc. As the country’s first and largest PPP hospital, it merges private sector innovation with public sector impact to deliver accessible, high-quality, and integrated care. From advanced diagnostics and critical care to human experience-driven services, Makati Life aims to set the gold standard for inclusive, patient-centered healthcare in the Philippines.

In photo (L–R): Dr. Alejandro R. Prieto, Chairman of the Board; Hon. Luis Jose Angel N. Campos, Jr., Makati City District 2-Congressman; Hon. Mar-Len Abigail S. Binay, Makati City Mayor; Dr. Dennis L. Sta. Ana, MLMC President & CEO; Hon. Monique Yazmin Maria Q. Lagdameo, Makati City Vice Mayor; Mr. Ruben Diego Picardo, MLMC Board Member; Hon. Romulo V. Peña Jr., Makati City District 1-Congressman; Mr. Johnny L. Uy, MLMC Board Member; Engr. William Russel M. Scheirman, Jr., Board Member & Chief Finance Officer
In photo (L–R): Dr. Dennis L. Sta. Ana, Mr. Johnny L. Uy, and Engr. William Russell M. Schierman, Jr., Founders of Makati Life Medical Center

Kaikoukai Healthcare Group awarded Medical Tourism Hospital of the Year - Japan

The Nagoya Kyoritsu Hospital is bringing a new level of reassurance to medical tourism in Japan.

Kaikoukai Healthcare Group is proud to announce that Nagoya Kyoritsu Hospital has been awarded the Medical Tourism Hospital of the Year - Japan at Healthcare Asia Awards 2025, in recognition of its outstanding support system for international patients. Since initiating health checkups for foreign nationals in 2010 and launching fullscale medical tourism services at Nagoya Kyoritsu Hospital in 2014, Kaikoukai Group has welcomed around 4,000 international patients annually, with a cumulative total of approximately 30,000 patients to date. The group also actively accepts dialysis patients from around the world. It draws on its expertise in dialysis treatment, which is one of Kaikoukai Healthcare Group’s core strengths, to provide safe and reliable care for travellers in need.

Why patients around the world choose

Kaikoukai Healthcare Group

Reliablesupportthroughmultilingualservices andspecialisedstaff

Interpreters fluent in five languages— English, Chinese, Indonesian, Portuguese, and Spanish—are always on-site to provide attentive support throughout the entire process, from inquiries and examinations to treatment and payment. Staff with deep cultural understanding ensure communication that is not only accurate but also compassionate and empathetic.

Creatingacomfortablespaceforpatients

The hospital is equipped with multilingual information boards, a dedicated waiting

area, special consultation rooms, and private inpatient rooms. These features allow patients to receive care in an environment that balances privacy with comfort.

Zeroconcernsaboutfood

Special attention is given to meals during hospitalisation. Ingredient information and menus are translated, with accommodations made for various religious and cultural dietary needs.

Advancedmedicalcaredrawingattention

One of the most highly praised treatments is Focused Ultrasound Therapy (FUS) for

essential tremor. This revolutionary method offers effective results with just a single session and has received significant acclaim from international patients, particularly those with Parkinson’s disease or essential tremor.

Connectingwiththeworldthroughthe fieldofmedicine

Nagoya Kyoritsu Hospital also welcomes numerous international doctors for observational visits and training. Its advanced medical technology and exceptional hospitality are shared and celebrated by medical professionals around the world.

Experience Japanese healthcare with Kaikoukai Healthcare Group

To ensure immediate medical care in case of illness during your stay, Nagoya Kyoritsu Hospital has established a comprehensive support system in collaboration with local accommodations and transportation services. This ensures that you can travel with confidence and peace of mind.

Looking ahead to the 2025 Osaka-Kansai Expo and the 2026 Asian Games, Nagoya Kyoritsu Hospital invites you to experience Kaikoukai Healthcare Group’s health checkups and medical services when visiting Japan.

Here, you will find “Reliability, Trust, and Exceptional Hospitality.”

Nagoya Kyoritsu Hospital invites you to experience Kaikoukai Healthcare Group’s health checkups and medical services

Dr Yamada Tetsuya, President of Kaikoukai Healthcare Corporation and Vice Chairperson of Kaikoukai Group, at the Healthcare Asia Awards 2025

How organisations must evolve to keep pace with advancements shaping today’s workforce

Gamze Yüceland, President of Takeda’s Growth and Emerging Markets (GEM) Business Unit, emphasised the role of employee development, mentorship, and fostering a multigenerational, inclusive workforce.

In her role as the President of Takeda’s Growth and Emerging Markets (GEM) Business Unit, Gamze Yüceland provides valuable insights into the importance of staying attuned to evolving work cultures and advancements shaping today’s workforce.

With nearly 30 years of experience, she has played a pivotal role in driving Takeda’s growth in complex markets. Her perspectives highlight the need to foster a culture that values, celebrates, and champions diversity, and ensure healthcare remains relevant to the unique needs of local populations.

How does employee development contribute to maintaining a workforce that stays relevant and adaptable?

More people today are looking at companies’ investments in people development when considering a new job opportunity.

Whilst there is a clear need for workplaces to provide the tools and an environment for their people to thrive, I also believe that we each have a responsibility to seek our own development. This involves possessing a mindset of lifelong learning and going beyond general interest to genuine curiosity.

Through our programmes at Takeda, we provide structured mentorship that connects employees with experienced leaders who can help guide their growth and career goals. Additionally, our Stretch Assignment programme is designed to offer

developmental opportunities that empower individuals to explore new horizons in a safe and supportive environment.

These programmes offer both short- and long-term assignments in different areas within Takeda, designed to accelerate learning, personal development, as well as goal achievement.

Could you share some key insights about the importance of embracing a multigenerational workforce?

A Deloitte survey found that 70% of organisations see multigenerational workforces as key to success in the next 12 to 18 months.

Our work on the ground is shaped by the insights and experiences of individuals from varied backgrounds and cultures who bring a deep empathy and understanding of the local challenges that influence healthcare needs.

Through our Next-Gen Advisory Board, we are bridging generations and amplifying the voices of all members of our global team. The Board includes individuals early in the industry, Millennials and Gen Z age groups, and reflects our diverse global population.

Members have the opportunity to collaborate with the Office of the CEO and to share their perspectives on company initiatives.

Additionally, in April 2023, Takeda Brazil received the Age Friendly Employer certification, an international seal that recognises organisations that prioritise inclusive practices and offer benefits like enhanced employee engagement, diverse perspectives, and a more supportive work environment for all age groups.

How can AI be utilised to support personalised career growth opportunities? By using data-driven insights, AI can help

individuals identify their strengths, areas for improvement, and tailored opportunities, empowering them to make informed decisions and reach their full potential.

Through our Career Navigator platform, our employees can personalise their career paths based on experience and interests, connecting with mentors for expertise and support.

How can organisations strengthen workplace mental health as well as foster a resilient and inclusive culture?

At Takeda, we’re committed to sparking open conversations, bringing our teams together, and nurturing a culture of inclusivity. We’ve created a tailored resource hub, employee assistance programmes, and well-being channels to support our team to highlight the importance of social, physical, financial, and emotional well-being.

For World Mental Health Day and DE&I Month, Takeda leaders shared strategies for fostering a resilient, inclusive culture through an online workshop. We also regularly host interactive workshops on psychological safety, where teams learn and discuss how to create safer, more supportive spaces within their own groups. In Australia, we are also proud to have been recognised as a Mental Health First Aid “Skilled” Recognised Workplace.

How can organisations adapt to changing work cultures, anticipate future trends, and what role do learning and development play?

At Takeda, we recognise the importance of championing learning and development. Every individual plays a vital role in fostering a culture that values diversity of experiences, thoughts, and perspectives. This is crucial to staying relevant to the ever-evolving healthcare needs of local populations. By empowering our people to grow and contribute their unique insights, we can better meet the complex demands of healthcare today and in the future.

At Takeda, we recognise the importance of championing learning and development
Gamze Yüceland, President of Growth and Emerging Markets (GEM) Business Unit, Takeda
Takeda Pharmaceuticals International AG. All rights reserved. Takeda and the Takeda logo are registered trademarks of Takeda Pharmaceutical Company Limited. Third parties’ copyrights are protected by law.
on Takeda.

Your Health, Our Priority

Sri Kota Specialist Medical Centre, your trusted specialist medical centre

24-Hour Emergency Services

Outpatient and Inpatient Services

Medical Imaging (MRI, CT Scan, X-Ray, etc.)

Surgery and Operating Theatre Services

Clinical Laboratory and Blood Bank Services

Diagnostic Procedures (Endoscopy, Colonoscopy & Bronchoscopy)

Haemodialysis Centre

Sri Kota Specialist Medical Centre (Sri Kota) was established in 1999 and is strategically located in the heart of Klang. As a leading private specialist hospital in Klang, we are committed to delivering excellence in healthcare with a patient- centred approach, offering comprehensive and high-quality medical services.

Sri Kota provides specialist outpatient services, inpatient care, precise diagnostics, surgical treatments & 24-hour emergency services ensuring every patient receives professional, accurate, and efficient medical care.

iKang Healthcare Group wins two accolades at 2025 Healthcare Asia Awards

The first specialised health check-up provider in Mainland China to receive the Healthcare Asia Awards, iKang Healthcare Group won two accolades for its innovative medical services.

Leveraging cutting-edge technologies such as genetic testing, artificial intelligence, and medical cloud computing, iKang continues to deepen its expertise in smart healthcare, driving the industry toward greater intelligence and precision.

Prioritising chronic disease management and early cancer screening

iKang Healthcare Group is one of the largest service providers in China’s preventive healthcare sect. The group serves about 10 million individuals annually. Since its establishment, iKang has introduced the health risk assessment into China and is now operating more than 170 medical centres in the Greater China Area, presenting the innovative concept of 360° comprehensive health management.

For example, in response to rising prevalence of cardiovascular and cerebrovascular diseases, known as the “number one killer,” threatening the lives and health of the Chinese population—iKang launched the iKang Cardiac Rehabilitation Center in 2022. This centre focusses on cardiopulmonary health management and cardiac rehabilitation, utilising advanced cardiopulmonary function assessment and rehabilitation exercise equipment, as well as advanced imaging equipment such as CT and MRI. It offers screening for major cardiovascular and cerebrovascular diseases, comprehensive evaluation of cardiopulmonary and cardiovascular risks, and provides personalised rehabilitation services for patients undergoing cardiac improvement and recovery.

iKang has established iKang Pediatric Growth & Development Center, iKang • Her Center, and iKang Rejuve Center. Building

on comprehensive medical examinations, iKang has gradually developed an integrated health management approach that extends from “assessment” to “management.”

In the field of cancer prevention and control, iKang remains at the forefront of the industry. Since 2017, iKang has been actively advancing cancer early screening initiatives. By introducing genetic testing and artificial intelligence into diagnosis, iKang is pioneering solutions for the early detection, early diagnosis, and early treatment of some of the most common cancers in China, including lung cancer, colorectal cancer, gastric cancer, liver cancer, esophageal cancer, cervical cancer, bladder cancer, and ovarian cancer.

AI empowerment drives accessibility of quality healthcare

iKang launched its own medical cloud in 2021 and has established the largest cloud-based digital platform in China’s health check-up industry with about 10 million annual users. To date, it has accumulated approximately 80 million health examination records, comprising iKang Health Examination Cloud, iKang Imaging Cloud, iKang ECG Cloud, and iKang Laboratory Cloud.

As early as 2018, iKang launched the iKangAI+ platform, introducing artificial intelligence into health examination services. Over the past seven years, more than ten AI screening solutions have been utilised, covering screenings for TB and lung cancer, retinal disease and diabetes, breast cancer, heart disease, cerebrovascular disease, dental health, bone density, and joint disease. These AI screening products, deployed on the cloud, can analyse

images in real-time, significantly reducing the time doctors need to review them and improve the diagnosis accuracy. The AI helps alleviate the shortage of experienced specialists, thereby promoting equal access to medical resources. If further examination and treatment is required, doctors can make wellinformed recommendations and referrals.

In 2023, iKang developed and launched the industry’s first AI digital health manager “iKKie.” iKKie is an LLM-based chatbot designed to handle real-world patient inquiries on medical reports and beyond.

Launched the IaaS open platform to build a new ecosystem for preventive care

At the end of 2024, iKang announced the launch of the IaaS open platform, offering Innovation/Infrastructure as a Service to third-party health check-up centres and medical institutions and establishing iKang as an open platform. Through iKangCloud+ and iKangOS+, iKang IaaS platform provides third-party health examination centres and medical institutions with access to its validated AI technologies and genetic testing solutions used by millions of users each year. It also gives a complete set of operational and management systems, developed over 20 years, creating an open ecosystem.

Regarding the launch of IaaS Platform, Mr Lee Ligang Zhang, the founder, chairman and CEO of iKang Healthcare Group, stated that iKang’s goal is not only to become a leading provider of medical examination services, but also to promote the accessibility of high-quality medical services through technological innovation and collaborative sharing, offering more people more efficient and effective health management services.

iKang Healthcare Group is a leading AI-driven cloud-based health management digital platform

Leveraging artificial intelligence, genetic testing and big data, iKang's smart healthcare platform effectively connects users/patients with their medical and health data, providing precise health management and personalized medical services.

At the end of 2024, iKang announced the launch of the IaaS Platform, offering Innovation/Infrastructure as a service to third party health examination centers and medical institutions, and establishing iKang as an open platform.

Through iKangCloud+ and iKangOS+, iKang IaaS platform makes its validated AI technologies, genetic testing solutions, and a complete set of operational and management systems, developed over 20 years, available to third-party health examination centers and medical institutions, thereby creating an open ecosystem.

The next strategic direction for iKang’s international expansion is to replicate its in-depth experience with artificial intelligence and precision diagnostics in the Southeast Asian market. Through the open platform model, iKang aims to build up local partnership to develop the preventive healthcare system in Southeast Asian.

Award-Winning Innovation: PicoSure® Pro Sets New Benchmark in Picosecond Laser Technology

PicoSure®® Pro takes picosecond laser technology to unprecedented levels of performance.

Cynosure® Lutronic® brought home the Aesthetic Product Innovation of the Year category win at the Healthcare Asia Medtech Awards 2024 for its 755nm picosecond alexandrite wavelength device PicoSure® Pro that has been introduced across Asia since its launch in end-2022.

PicoSure® Pro

PicoSure® Pro delivers ultra-short pulses of energy to the skin through its advanced laser technology. It is able to deliver a more effective solution than before with its adjustable fluences, 50% more power, Turbo mode for hard to treat areas, platinum focus lens, faster start-up time, a new zoom handpiece, and optional wavelengths.

The device also allows for a much higher melanin to blood absorption ratio compared to other common picosecond wavelengths. It effectively targets melanin without the risk of pinpoint bleeding and causing other side effects, treating unwanted pigmentation in all skin types, reducing wrinkles, acne scars, and temporarily reducing pores with no downtime. PicoSure® Pro has been cleared by the FDA for treating melasma pigment, nevus of Ota, as well as Hori’s nevus.

Moreover, PicoSure® Pro has caught the interest of practitioners, publishing research studies about its cutting-edge technology and greater efficiency in providing patients with better outcomes. As of the moment, there have been 127 peer-reviewed studies published about the technology, with another eight currently in progress.

“PicoSure® Pro is an excellent option for the region’s practitioners to personalise, offer better and faster treatments to patients with a variety of skin concerns yet achieve optimal results, with minimal pain or downtime leading to improved outcomes, increased patient satisfaction and hence, better returns on investment (ROI) to practices and clinics,” Cynosure® Lutronic® said.

Empowering healthcare professionals

Meanwhile, this technology also empowers doctors to transform patients’ lives as

“Combining PicoSure® Pro’s 755nm wavelength and picosecond pulse width and Platinum Focus lens to perfectly calculate for optimum LIOB formation and placement, delivering energy that works with the body, unleashing natural cell signalling processes to create brighter, healthier, younger-looking skin with virtually no downtime,” the company added.

Healthcare Asia Medtech Awards spotlights exceptional medtech companies across Asia who have consistently gone

to personalise, offer better and faster treatments

Leading medical providers, innovations lauded at Healthcare Asia Awards 2025

Healthcare excellence took centre stage at the Healthcare Asia Awards, Healthcare Asia Medtech Awards, and Healthcare Asia Pharma Awards, where visionaries driving innovation across the industry were celebrated. From groundbreaking advancements in patient care to revolutionary developments in pharmaceuticals and medical technology, this year’s winners have set new benchmarks for excellence.

The awards programmes honoured the bold ideas and transformative solutions, recognising the passion, dedication, and ingenuity that continue to push the industry forward and shape the future of healthcare.

In recognition of his leadership in smart healthcare, Dr Der-Yang Cho of China Medical University Hospital was named CEO of the Year. He has driven digital transformation, biomedical innovation, and a patientfirst approach that has established CMUH as a global pioneer.

“Thank you very much for this recognition for the China Medical University Hospital in Taiwan,” Cho said upon receiving his award, whilst expressing his gratitude for the hospital’s recognition. “We also dedicate it to the team in charge of CAR-T therapy. In CAR-T therapy, we focus on allogeneic CAR-T therapy for solid tumours, now with approval by the U.S.

HealthcareAsia congratulates the following winners:

The Aga Khan University Hospital, Pakistan

• Customer Service Initiative of the Year - Pakistan

• Delivery Innovation Initiative of the Year - Pakistan

Alluri Sitarama Raju Academy of Medical Sciences

• Most Improved Community Hospital of the Year - India

Asian Hospital and Medical Center

• Workforce Transformation Initiative of the Year - Philippines

Avisena Specialist Hospital

• Specialty Hospital of the Year (Gastroenterology) - Malaysia

Avisena Women’s & Children’s Specialist Hospital

• Specialty Hospital of the Year (Women’s & Children’s) - Malaysia

Bagan Specialist Centre

• Facilities Improvement Initiative of the Year - Malaysia

Bangkok Hospital

• Specialty Hospital of the Year - Thailand

Bangkok Hospital Chiangmai

• Customer Service Initiative of the Year - Thailand

Bangkok Hospital Pattaya

• Marketing Initiative of the Year - Thailand

Bataan St. Joseph Hospital & Medical Center Corp

• Education & Training Initiative of the Year - Philippines

BDMS Wellness Clinic

• Health and Wellness Initiative of the Year - Thailand

• Health Promotion Initiative of the Year - Thailand

BIMC Nusa Dua

• Medical Tourism Hospital of the Year - Indonesia

Buch International Hospital

• Hospital of the Year - Pakistan

• Technology Innovation of the Year - Pakistan

FDA and Taiwan FDA. Thank you for giving us this recognition.”

Hosted by Healthcare Asia, this year’s prestigious Awards Dinner brought together industry leaders and innovators on 10 April 2025 in Malaysia. The event attracted over 400 attendees, making it the largest awards dinner of the Healthcare Asia Awards to date.

The event showcased hospitals, medtech firms, and pharmaceutical companies spearheading groundbreaking solutions, life-saving technologies, and industry-leading advancements.

A distinguished panel of industry leaders and experts served as this year’s judges, which included Abhay Bangi, Partner, Strategy & Transaction, ASEAN Healthcare Lead, EY-Parthenon; Peter Liddell, Leader for Healthcare and Life Sciences, Singapore, Leader for Life Sciences Asia Pacific, KPMG; Dr Stephanie Allen, Senior Partner, Leader of Healthcare & Life-sciences Asia Pacific, Kearney; Chris Hardesty, Partner, Pureland Venture; Kavita Rekhraj, Life Sciences & Health Care Industry Leader, Deloitte Asia Pacific & Southeast Asia; and Dr Feras Mahdi, Partner, L.E.K. Consulting.

Bumrungrad International Hospital

• Hospital of the Year - Thailand

Cagayan Valley Medical Center

• Management Innovation of the Year - Philippines

Camp Siongco Station Hospital

• Military Healthcare Provider of the Year - Philippines

CAPITOL MEDICAL CENTER

• Public Health Initiative of the Year - Philippines

Chang Gung Memorial Hospital, Linkou

• Service Innovation of the Year - Taiwan

Chang Gung Memorial Medical Foundation

Chiayi Chang Gung Memorial Hospital

• ESG Program of the Year - Taiwan

Chong Hua Hospital

• Customer Service Initiative of the Year - Philippines

Chong Hua Medical Mall

• Outpatient Service Initiative of the Year - Philippines

Dar Al Shifa Hospital

• Hospital of the Year - Kuwait

• Patient Safety Initiative of the Year - Kuwait

Dhulikhel Hospital, Kathmandu University School of Medical Sciences

• Primary Care Provider of the Year - Nepal

Dr Sulaiman Al Habib Medical Group

• Patient Safety Initiative of the Year - Saudi Arabia

• Service Innovation of the Year - Saudi Arabia

Emirates International Hospital

• Diagnostics Provider of the Year - UAE

• Hospital of the Year - UAE

Femto Research Group Co., Ltd.

• Service Innovation of the Year - Thailand

GAOC Dental Clinic Gan Advanced Osseointegration Center

• Dental Clinic of the Year - Philippines

• Medical Tourism Initiative of the Year - Philippines

Healthserv Los Baños Medical Center

• Infection Control Initiative of the Year - Philippines

Healthway Medical Network (HMN)

• Specialty Clinic of the Year - Philippines

• Vaccination Delivery of the Year - Philippines

Heartology Cardiovascular Hospital

• Marketing Initiative of the Year - Indonesia

HIV Treatment & Support Centre PMC Hospital Nawab Shah

• Most Improved Community Hospital of the Year - Pakistan

Hospital Management Services Company Limited

• Home-care Initiative of the Year - Thailand

iKang Healthcare Group

• Diagnostics Provider of the Year - China

• Specialty Clinic of the Year - China

INSTITUT JANTUNG NEGARA

• Technology Innovation of the Year - Malaysia

• Smart Hospital Initiative of the Year - Malaysia

Intermed Hospital

• Hospital of the Year - Mongolia

Jabatan Kesihatan Wilayah Persekutuan Kuala Lumpur & Putrajaya

• ICT Initiative of the Year - Malaysia

JEN-AI Hospital

• Patient Safety Initiative of the Year - Taiwan

Johor Specialist Hospital

• ESG Program of the Year - Malaysia

Jomtien Hospital

• Clinical Service Initiative of the Year - Thailand

Jose B. Lingad Memorial General Hospital

• Technology Innovation of the Year - Philippines

Kaikoukai Healthcare Group Nagoya Kyoritsu Hospital

• Medical Tourism Hospital of the Year - Japan

Kan Thar Yar International Specialist Hospital

• Clinical Service Initiative of the Year - Myanmar

Kaohsiung Chang Gung Memorial Hospital

• Clinical Service Initiative of the Year - Taiwan

Kaohsiung Municipal Fong Shan Hospital - Under the management of Chang Gung Medical Foundation

• Service Delivery Innovation Initiative of the Year - Taiwan

King Khalid Hospital Alkharj- Member of Riyadh First Health Cluster

• Allied Health Initiative of the Year - Saudi Arabia

• Customer Service Initiative of the Year - Saudi Arabia

King Salman General Hospital

• Clinical Service Initiative of the Year - Saudi Arabia

King Salman Hospital

• Secondary Hospital of the Year - Saudi Arabia

KMI Healthcare

• Customer Service Initiative of the Year - Malaysia

KMI Taman Desa Medical Centre

• Secondary Hospital of the Year - Malaysia

KPJ Perdana Specialist Hospital

• Specialty Hospital of the Year (Orthopedic) - Malaysia

Makati Life Medical Center

• Integrated Healthcare Provider of the Year - Philippines

Mariano Marcos Memorial Hospital and Medical Center

• Health Promotion Initiative of the Year - Philippines

Mayapada Healthcare Group

• Customer Service Initiative of the Year - Indonesia

• Patient Safety Initiative of the Year - Indonesia

Medi Linx Laboratory Inc.

• Laboratory Initiative of the Year - Philippines

Medical Center Manila, Inc.

• Tertiary Hospital of the Year - Philippines

Mental Health Service

• Health Promotion Initiative of the Year - Qatar

• Patient Care Initiative of the Year - Qatar

Moe Kaung Treasure Maternal and Child Hospital

• Tertiary Hospital of the Year - Myanmar

MRCCC Siloam Hospitals Semanggi

• Specialty Hospital of the Year (Oncology) - Indonesia

National Cardiovascular Center Harapan Kita

• Health Promotion Initiative of the Year - Indonesia

• Management Innovation of the Year - Indonesia

National Hospital

• ICT Initiative of the Year - Indonesia

New Taipei Municipal Tucheng Hospital (built and Operated by Chang Gung Medical Foundation)

• Management Innovation of the Year - Taiwan

Ojin LLC

• Specialty Hospital of the Year - Mongolia

Optimax Eye Specialist Centre

• Specialty Hospital of the Year (Ophthalmology) - Malaysia

Oriental Melaka Straits Medical Centre

• Patient Safety Initiative of the Year - Malaysia

Our Lady of Lourdes Hospital

• Marketing Initiative of the Year - Philippines

P.D. Hinduja Hospital and MRC

• Service Delivery Innovation Initiative of the Year - India

Pakistan Kidney and Liver Institute and Research Center

• Specialty Hospital of the Year - Pakistan

• Tertiary Hospital of the Year - Pakistan

Perpetual Help Medical Center - Las Piñas

• Health and Wellness Initiative of the Year - Philippines

Princ Hospital Suvarnabhumi

• ESG Program of the Year - Thailand

• Patient Safety Initiative of the Year - Thailand

• Specialty Clinic of the Year - Thailand

Prince Court Medical Centre

• Clinical Service Initiative of the Year - Malaysia

• Medical Tourism Hospital of the Year - Malaysia

Prince of Wales Hospital

• Customer Service Initiative of the Year - Hong Kong

Qassim National Hospital

• Facilities Improvement Initiative of the Year - Saudi Arabia

• Hospital of the Year - Saudi Arabia

EVENT: HEALTHCARE ASIA AWARDS

Radlink Philippines Corporation

• Service Innovation of the Year - Philippines

Regency Specialist Hospital

• Marketing Initiative of the Year - Malaysia

Riverside Bacolod Cancer Care Center

• Patient Care Initiative of the Year - Philippines

Rizal Medical Center

• Allied Health Initiative of the Year - Philippines

• Clinical Service Initiative of the Year - Philippines

• Service Delivery Innovation Initiative of the Year - Philippines

RS Persahabatan

• Employee Engagement of the Year - Indonesia

• Patient Care Initiative of the Year - Indonesia

RS Pondok Indah Group

• Diagnostics Provider of the Year - Indonesia

• Hospital of the Year - Indonesia

• Service Innovation of the Year - Indonesia

RUMAH SAKIT JIH

• Technology Innovation of the Year - Indonesia

Saigon Eye Hospital

• Health and Wellness Initiative of the Year - Vietnam

• Specialty Hospital of the Year - Vietnam

School of Dentistry Shaheed Zulfiqar Ali Bhutto Medical University

• Health and Wellness Initiative of the Year - Pakistan

Self-Check-In Siloam Hospitals Group

• Service Delivery Innovation Initiative of the Year - Indonesia

Siloam Hospitals ASRI for Kidney Transplant

• Tertiary Hospital of the Year - Indonesia

Stroke Ready Hospitals Siloam Hospitals Group

• Clinical Service Initiative of the Year - Indonesia

Shonan Kamakura General Hospital

• Hospital of the Year - Japan

Show Chwan Memorial Healthcare System

• Tertiary Hospital of the Year - Taiwan

Singapore Diagnostics

• Diagnostics Provider of the Year - Philippines

• Facilities Improvement Initiative of the Year - Philippines

• ICT Initiative of the Year - Philippines

Soeharto Heerdjan Hospital

• Specialty Hospital of the Year (Psychiatric) - Indonesia

Southern Medicare Sdn Bhd

• Employee Engagement of the Year - Malaysia

• Health and Wellness Initiative of the Year - Malaysia

Sunway Medical Centre Velocity

• Health Promotion Initiative of the Year - Malaysia

Sunmed@Home Sdn Bhd

• Home-care Initiative of the Year - Malaysia

Sunway Fertility Centre

• Medical Tourism Initiative of the Year - Malaysia

Sunway Medical Centre Sdn. Bhd.

• Hospital of the Year - Malaysia

Sunway TCM Sdn Bhd

• Patient Care Initiative of the Year - Malaysia

Taipei Municipal Wanfang Hospital

• Patient Care Initiative of the Year - Taiwan

Taoyuan Chang Gung Memorial Hospital

• Smart Hospital Initiative of the Year - Taiwan

Tawam Hospital

• Health and Wellness Initiative of the Year - UAE

The Beekeeper Group

• Technology Innovation of the Year - Thailand

The Medical City

• Hospital of the Year - Philippines

• Public-private Healthcare Partnership of the Year - Philippines

The Medical City Clark

• Patient Safety Initiative of the Year - Philippines

The Medical City Clinic

• Primary Care Provider of the Year - Philippines

The Medical City Iloilo Hospital, Inc

• Secondary Hospital of the Year - Philippines

Thomson Hospitals Sdn Bhd

• Specialty Hospital of the Year (Pulmonary) - Malaysia

Vinmec International General Hospital Joint Stock Company

• Hospital Group of the Year - Vietnam

• Technology Innovation of the Year - Vietnam

WQ PARK HEALTH & REHABILITATION CENTRE

• Allied Health Initiative of the Year - Malaysia

China Medical University Hospital

• Hospital of the Year - Taiwan

Dr Der-Yang Cho, China Medical University Hospital

• CEO of the Year

HEALTHCAREASIA MEDTECHAWARDS 2025 WINNERS

Abbott Diabetes Care

• Digital Innovation of the Year - Singapore

• Health & Wellness Initiative of the Year - Japan

CooperVision

• Marketing & Communications Initiative of the Year - Singapore

Cryoviva (Thailand),.Ltd

• Health and Wellness Initiative of the Year - Thailand

Cynosure® Lutronic®

• Aesthetic Product Innovation of the Year

Dexcom Malaysia

• Initiative Award - Malaysia

DKSH Healthcare

• ESG Program of the Year - Thailand

• Hospital Partnership of the Year - Thailand

GE HealthCare

• Cardiology Product Innovation Award - Singapore

• Employee Engagement of the Year - Korea

Hartalega NGC Sdn Bhd

• ESG Program of the Year - Malaysia

• Product Innovation Award - Malaysia

Karaz Platform

• Digital Innovation of the Year - Saudi Arabia

Medtronic

• Employee Engagement Initiative of the Year - Turmeca

Medtronic

• Patient Advocacy Program of the Year - South Korea

Medtronic Malaysia Sdn Bhd

• Hospital Partnership of the Year - Malaysia

Medtronic Philippines, Inc.

• Digital Innovation of the Year - Philippines

• Hospital Partnership of the Year - Philippines

QIAGEN MANILA, INC.

• Employee Engagement of the Year - Philippines

Urgo Medical

• Marketing & Communications Initiative of the Year - Australia

• Marketing & Communications Initiative of the Year - Vietnam

HEALTHCAREASIA PHARMAAWARDS 2025 WINNERS

A.MENARINI SINGAPORE PTE. LTD. (MALAYSIA)

• Marketing & Communications Initiative of the Year - Malaysia

Alpro Alliance Sdn Bhd

• Patient Advocacy Program of the Year - Malaysia

• Sustainability Initiative of the Year - Malaysia

Cipla EMEU

• ESG Program of the Year - India

• Most Differentiated Service of the Year - India

Dr. Reddy’s Laboratories Ltd.

• Digital Innovation of the Year - India

• Supply Chain Initiative of the Year - India

FPT Long Chau Pharma Joint Stock Company

• Digital Innovation of the Year - Vietnam

iNova Pharmaceuticals Inc.

• Marketing & Communications Initiative of the Year - Philippines

Körber Pharma Software Ltd.

• Digital Innovation of the Year - Thailand

MedEthix Inc

• Hospital Partnership of the Year - Philippines

• Most Differentiated Service of the Year - Philippines

MEGHMANI LIFESCIENCES LTD

• Health and Wellness Initiative of the Year - India

• Patient Advocacy Program of the Year - India

Merck Healthcare Vietnam

• Employee Engagement of the Year - Vietnam

• Sustainability Initiative of the Year - Vietnam

Neuland Laboratories Limited

• Sustainability Initiative of the Year - India

Novartis Corporation (Malaysia) Sdn. Bhd.

• Digital Innovation of the Year - Malaysia

• Supply Chain Initiative of the Year - Malaysia

Roche Products Saudi Arabia L.L.C.

• Outcomes-based Contracting Model of the Year - Saudi Arabia

UCB JAPAN COMPANY LTD.

• ESG Program of the Year - Japan

Yakin Medic Sdn Bhd

• R&D Initiative of the Year - Malaysia

Asian Hospital and Medical Center
The Aga Khan University Hospital, Pakistan
Avisena Specialist Hospital
Avisena Women’s & Children’s Specialist Hospital
Bagan Specialist Centre and Oriental Melaka Straits Medical Centre
Bangkok Hospital Chiangmai

EVENT: HEALTHCARE ASIA AWARDS

Bataan St. Joseph Hospital & Medical Center Corp
Chang Gung Memorial Medical Foundation Chiayi Chang Gung Memorial Hospital
BIMC Nusa Dua, Siloam Hospitals Group, and Siloam Hospitals ASRI for Kidney Transplant
BDMS Wellness Clinic
Buch International Hospital
China Medical University Hospital, Taiwan
GAOC Dental Clinic - Gan Advanced Osseointegration Center
Capitol Medical Center
Chong Hua Hospital
Chong Hua Medical Mall
Healthway Medical Network (HMN) iKang Healthcare Group
Femto Research Group Co., Ltd
Chang Gung Memorial Hospital, Linkou
Bangkok Hospital Bangkok Hospital Pattaya and Jomtien Hospital
King Khalid Hospital Alkharj- Member of Riyadh First HealthCluster
King Salman General Hospital and King Salman Hospital
Moe Kaung Treasure Maternal and Child Hospital
National Cardiovascular Center Harapan Kita
KMI Healthcare and KMI Taman Desa Medical Centre
Kaohsiung Municipal Fong Shan Hospital - Under the Management of Chang Gung Medical Foundation
Kaikoukai Healthcare Group Nagoya Kyoritsu Hospital
Institut Jantung Negara
Kan Thar Yar International Specialist Hospital Kaohsiung Chang Gung Memorial Hospital
Makati Life Medical Center
Medical Center Manila, Inc
New Taipei Municipal Tucheng Hospital Ojin LLC
Mayapada Healthcare Group
MRCCC Siloam Hospitals Semanggi
Medi Linx Laboratory Inc

EVENT: HEALTHCARE ASIA AWARDS

Prince Court Medical Centre
Rizal Medical Center
Rumah Sakit JIH
Singapore Diagnostics
Soeharto Heerdjan Hospital
Saigon Eye Hospital
Shonan Kamakura General Hospital
Show Chwan Memorial Healthcare System
RS Persahabatan
RS Pondok Indah Group
Radlink Philippines Corporation Regency Specialist Hospital
Pakistan Kidney and Liver Institute and Research Center
Optimax Eye Specialist Centre
Perpetual Help Medical Center - Las Piñas Princ Hospital Suvarnabhumi
Our Lady of Lourdes Hospital
Sunway Medical Centre Velocity, Sunmed@Home Sdn Bhd, Sunway Fertility Centre, Sunway TCM Sdn Bhd, and Sunway Medical Centre Sdn. Bhd
Southern Medicare Sdn Bhd Taipei Municipal Wanfang Hospital
Taoyuan Chang Gung Memorial Hospital
The Beekeeper Group Vinmec HealthCare System
Abbott Diabetes Care
Cryoviva (Thailand),.LTD
Cynosure® Lutronic®
GE HealthCare
Urgo Medical
Cipla EMEU and Cipla Limited
Dexcom Malaysia
DKSH Healthcare
The Medical City, The Medical City Clark, The Medical City Iloilo Hospital, Inc, and The Medical City Clinic

EVENT: HEALTHCARE ASIA AWARDS

FPT Long Chau Pharma Joint Stock Company
Merck Healthcare Vietnam
Novartis Corporation (Malaysia) Sdn. Bhd
UCB Japan Company Ltd
iNova Pharma Phils. Inc
Körber Pharma MedEthix Inc
A. Menarini Singapore Pte. Ltd. (Malaysia)

Transforming mental health services in Indonesia: The vision of Soeharto Heerdjan Hospital

Amidst the rising global awareness of mental health, stigma continues to present a major obstacle—particularly in Southeast Asia. In Indonesia, Soeharto Heerdjan Hospital (RSSH), a longstanding mental hospital in Jakarta, is breaking down these barriers through a holistic and futurefacing approach. By combining innovation, public outreach, and systemic reform, RSSH is repositioning itself not only as a referral centre but also as a centre for excellent neuropsychiatric services.

Tackling

stigma through education and engagement

One of RSSH’s most notable achievements lies in its multifaceted strategy to combat stigma. RSSH has implemented educational campaigns through webinars, live talk shows, interactive social media, and strategic partnerships with the community, institutions, and NGOs. These initiatives are aimed at fostering a better understanding of mental health across the full spectrum of care (promotive, preventive, curative, and rehabilitative). RSSH has also increased its use of digital platforms, leveraging video content, podcasts, and live radio programmes to make mental health information more accessible, especially for remote and underserved populations.

Internal reforms and innovative programmes

Internally, RSSH is undergoing a significant transformation—rebranding itself from a traditional mental hospital to a centre of excellence in mental health services.

This transformation is reflected in both service delivery and institutional identity. RSSH continues to work consistently and professionally to improve the quality of both inpatient and outpatient services, including general psychiatry, depression, bipolar disorder, anxiety, addiction, and hypnotherapy service. The hospital also has prioritised infrastructure upgrades and expanded access to care through telemedicine, homecare, and emergency psychiatric evacuation (named as SEJIWA).

Now, technology is playing a central role in mental health care. RSSH utilises advanced therapeutic tools such as Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), and Neurofeedback as part of its standard treatment repertoire, integrating modern science into patient care.

Specific programmes for the vulnerable Introduced in 2022, KUAS BIRU is a structured day care initiative focussing on children aged 10 to 18 years who are living with ADHD, autism, or learning difficulties. Designed to support eight psychological domains—cognitive, emotional, behavioural, sensorimotor, social communication, language, psychosocial, and daily functioning— the programme combines therapeutic engagement with developmental support.

The impact has been measurable. Between 2022 and 2023, the KUAS BIRU programme recorded a 32.5% increase in participants, with 807 children served. In parallel, outpatient psychiatric visits for young people rose by 26%, totalling 25,013 visits. These numbers reflect the growing demand for youth-specific mental health services and the public’s increasing confidence in such programmes.

Similarly, RSSH responded to the unique mental health needs of the elderly by launching the TERATAI day care programme in 2023. This service addresses common geriatric mental health issues such as loneliness, anxiety, inactivity, and familial disengagement. TERATAI evolved into OPSI (One Stop Psychogeriatry Services), which now offers a seamless integration of outpatient, inpatient, day care, and respite care services.

From 2023 to 2024, OPSI recorded a 55.3% increase in elderly patients (321 individuals) and a 13% rise in outpatient visits (2,860

in total). These results highlight a growing recognition of mental health as a fundamental part of healthy ageing.

Responding to challenges

Despite these achievements, RSSH faces considerable challenges. One of the challenges is the need to strengthen its workforce—both medical and non-medical— and improve infrastructure to align with WHO-Quality Rights (WHO-QR) standards. Additionally, rapid advancements in mental health technologies demand continuous training and substantial investment. Indonesia’s geographical diversity also poses a barrier to access. In response, RSSH has adopted a mentoring system and expanded telemedicine services, making mental health care more inclusive. Its role as a regional referral hospital—serving areas in Sumatra and parts of Java—further extends its influence across the archipelago.

Looking Ahead

RSSH’s commitment to innovation, inclusion, and excellence positions it as a model in Asia’s mental health landscape. Through transformative clinical and social strategies, RSSH advances access, reduces stigma, and promotes a rights-based approach to care. By integrating technology in diagnostics and therapy, it shifts beyond traditional models—delivering modern mental health services that uphold human dignity and equity, whilst creating meaningful change within communities and the healthcare system.

RSSH advances access, reduces stigma, and promotes a rightsbased approach to care

Dr Desmiarti, SpKJ, MARS (CEO of Soeharto Heerdjan Hospital)
Soeharto Heerdjan Hospitals’ Teratai and Kuas Biru day care programmes

Cynosure® Lutronic® takes home win at Healthcare Asia Medtech Awards 2025

Medical device system manufacturer Cynosure® Lutronic® scores another win with Aesthetic Product Innovation of the Year in the prestigious Healthcare Asia Medtech Awards 2025 for its specialised vascular laser DermaV™ that offers unmatched precision, safety, and effectiveness in treating vascular and pigmented lesions.

Designed as a faster, safer, and more versatile solution, DermaV is the first and only digital-powered dual-wavelength 532nm & 1064nm laser to feature both an Integrated Cooling Device (ICD) and Variable Sequential Pulsing (VSP) capabilities. By optimising wavelength, fluence, and pulse width, it delivers superior treatment outcomes with minimal discomfort, setting a new benchmark in dermatology and treating unwanted vascular and pigmented lesions.

All-in-one solution

This innovative platform has the capability to replace multiple older laser technologies as a comprehensive all-in-one solution, empowering dermatologists with efficiency, precision, and superior clinical outcomes. DermaV has been featured at multiple podium presentations across the APAC region, earning recognition for its breakthrough technology, superior efficacy, and enhanced patient outcomes for all skin types, including darker skin types.

“We are honoured to receive this recognition. This achievement underscores

our commitment to empowering doctors with cutting-edge solutions that enable them to deliver optimal patient care. It reaffirms our dedication to advancing medical technology, improving treatment outcomes, and expanding our presence across the region,” says Danielle Raballo, Cynosure Lutronic Asia Pacific.

Since its origins in Korea and initial launch in Vietnam in late 2021, DermaV™ has rapidly expanded across Southeast Asia, reaching Singapore, Indonesia, the Philippines, and

Thailand, with further expansion on the horizon.

About the awards

Healthcare Asia Medtech Awards spotlights the pioneers who are shaping the future of healthcare through medical devices, lifesaving software, or innovative healthcare solutions. Cynosure Lutronic’s latest recognition underscores its commitment to driving innovation and shaping the future of medical aesthetics.

‘This achievement underscores our commitment to empowering doctors with cutting-edge solutions’
Danielle Raballo at the Healthcare Asia Medtech Awards 2025

facebook.com/bsjhmc

HOSPITAL

A journey to global excellence: Vinmec and the rise of Vietnam’s healthcare sector

The Vinmec Healthcare System is redefining Vietnam’s private healthcare landscape.

Since the establishment of its first hospital in 2012, Vinmec has grown into a nationwide network of nine hospitals and four clinics, dedicated to reinvesting 100% of its earnings into research, clinical development, and broadening access to highquality healthcare services.

At the core of this model is a strong academic alliance with VinUniversity, uniting leading experts, researchers, and educators from Vietnam and abroad.

This robust academic foundation enables Vinmec to lead global medical advancements and spearhead the development of personalised, evidence-based care.

Mission-driven healthcare

Guided by a not-for-profit mission, Vinmec’s academic medicine model has led to the successful establishment of Vietnam’s first and only four internationally accredited Centers of Excellence in key specialties: cardiology, oncology, orthopaedics & sports medicine, and clinical immunology & allergy. These centres stand out for their advanced clinical expertise, state-of-the-art technology, and integrated strengths in research, training, and treatment, consistently meeting international benchmarks.

Vinmec has also made coordinated investments into cutting-edge medical technologies, including the Da Vinci robotic surgery system, 3.0 Tesla MRI, 256-slice CT, and AI-powered hybrid operating rooms. Additionally, the system is a national leader in the adoption of innovative therapies such as stem cell treatments, CAR-T cell therapy, as well as personalised 3D-printed implants, offering life-changing solutions for rare and complex conditions.

Committed to excellence across all dimensions, Vinmec holds numerous internationally recognised accreditations, including: JCI – the global “gold standard” for patient safety and healthcare quality, ACC –American College of Cardiology certification, AABB – Association for the Advancement of Blood & Biotherapies, and RTAC – accreditation for reproductive medicine in the Asia-Pacific region. These endorsements not only validate Vinmec’s world-class capabilities but also reflect its steadfast commitment to delivering safe, effective, and compassionate care.

Vietnam’s gateway to world-class healthcare

A defining strength of Vinmec lies in its globally connected and internationally standardised approach.

It is currently Vietnam’s first and only healthcare system to join Cleveland Clinic Connected, a global alliance led by Cleveland Clinic (USA) to share knowledge and elevate care standards worldwide.

Powered by cutting-edge technology, globally benchmarked standards, and a highly skilled medical team, Vinmec is not only serving domestic patients but also increasingly attracting international clients. From expatriates living in Vietnam to overseas patients seeking specialised care and surgical treatment, Vinmec is emerging as a trusted healthcare destination. With a premium care model and competitive pricing, Vinmec has been a catalyst, positioning Vietnam on the medical tourism map of Asia.

Most recently, Vinmec became the first and only healthcare system in Vietnam to be honoured with Hospital Group of the Year - Vietnam and Technology Innovation of the

- Vietnam at the Healthcare Asia Awards 2025, reaffirming Vinmec’s pioneering spirit and growing influence on the regional healthcare stage. With a long-term vision and strategic investment, Vinmec is playing a transformative role in advancing Vietnam’s healthcare sector, laying the groundwork for the country to emerge as an integrated regional hub of world-class research, treatment, and medical education.

About Vinmec

Vinmec is a leading not-for-profit healthcare system in Vietnam, established by Vingroup – one of the country’s largest private conglomerates. Since its founding in 2012, Vinmec has grown into a nationwide network of nine hospitals and four clinics, offering high-quality, patient-centred care across a wide range of specialties. With a strong emphasis on academic medicine, research, and international cooperation, Vinmec is committed to transforming Vietnam’s healthcare landscape and becoming a trusted destination for both domestic and international patients. For more information, please visit: https://www.vinmec.com/eng

Year
Mrs Lê Thúy Anh – Chief Executive Officer of Vinmec Healthcare System
Vinmec HealthCare System at the Healthcare Asia Awards 2025
Vinmec, the most recognised healthcare system amongst foreigners in Vietnam, has been honoured with two prestigious titles at the Healthcare Asia Awards 2025

GAOC wins two prestigious accolades at the Healthcare Asia Awards 2025

GAOC continues to elevate Philippine dental care, winning two top accolades at the Healthcare Asia Awards 2025 held in Kuala Lumpur, Malaysia.

In recognition of excellence and dedication to the healthcare industry, Gan Advanced Osseointegration Center (GAOC) proudly claimed two significant awards at the Healthcare Asia Awards 2025: Dental Clinic of the Year - Philippines and Medical Tourism Initiative of the Year - Philippines. These citations celebrate GAOC’s dedication to bringing world-class dental care and reaffirm its leadership in local and global healthcare landscapes.

Elevating Philippine dentistry

GAOC’s visionary approach to medical tourism has redefined how the world perceives the Philippines as a healthcare destination. It has grown into a recognised leader in dental tourism under the exceptional leadership of Dr Steve Mark Gan, when the first clinic was established in Makati in 2001 to combine cutting-edge dental technology with patient-centric care.

Recognising the global demand for highquality dental care, GAOC became one of the first dental clinics in the Philippines to attract overseas patients in 2003, and today it stands as a global destination for individuals seeking top-notch care and a premium experience.

Fast forward to 2025, GAOC has earned

recognition for its significant role in driving the country’s medical tourism industry, being

acknowledged for its efforts specifically in ensuring that both local and international patients are provided with world-class dental services through expert care. Through a special partnership with the Department of Tourism (DOT), GAOC secured full accreditation in August 2024 for its clinics, under the DOT’s medical and wellness tourism programme. This milestone has made GAOC the first dental network in the Philippines to earn such an esteemed distinction in the history of DOT.

Competing with major hospitals, dermatology, and other dental clinics in the Philippines, GAOC emerged as the top choice for the Medical Tourism Initiative of the Year - Philippines, solidifying its reputation as the country’s only premium and world-class multispecialty dental centre, with 10 branches across the Philippines.

Pioneering excellence in dental care

In addition to the recognition in medical tourism, GAOC was honoured with the Dental Clinic of the Year - Philippines award. From the very beginning, GAOC has been driven by Dr Gan’s vision to bring international-level expertise to Filipino patients. The introduction of revolutionary technologies ensures that GAOC stays ahead of the curve in providing the

most innovative treatments available.

GAOC’s Dental Academy, established in 2023, also plays a key role in expanding the reach of Philippine dental expertise. Bringing world-renowned dental experts to the Philippines, the academy offers Filipino practitioners the latest dental knowledge and attracts global dental professionals seeking advanced training.

The future of GAOC GAOC’s growth shows no signs of slowing down. The organisation’s expansion into new locations, including the Boracay satellite

branch and the latest luxury mall in 2024, the OPUS Mall clinic in Quezon City, is a clear reflection of its ongoing success and commitment to providing world-class care. These new locations will feature advanced technology, such as robotic dental surgery, another first for the Philippines. GAOC’s patient-centric approach continues to be the driving force behind its success.

As GAOC continues to innovate, educate, and expand, its mission to deliver exceptional dental care and world-class medical tourism experiences to patients from around the world never fails to prosper.

More smiles, more success

As GAOC celebrates these prestigious awards, the future remains bright for the institution as GAOC marks its 24th year this 2025. With continued expansion, cuttingedge technology, and a commitment to patient care, GAOC is setting new standards for excellence in dental care, not only in the Philippines but across the globe.

The team is more determined than ever to uphold its vision of making world-class dental care accessible, reliable, and, most importantly, life-changing.

GAOC’s commitment to integrating innovation and world-class service into every aspect of its operations ensures that it will continue to lead the charge in the medical tourism and dental care industries for years to come, leaving patients with a healthy smile and a memorable experience that exemplifies the very best in healthcare.

GAOC received two accolades at the Healthcare Asia Awards held 10 April 2025
Gan Advanced Osseointegration Center (GAOC)
Dr Steve Mark Gan with GAOC’s two awards
There is always more to be done

Our commitment to improving the lives of people with severe diseases runs deep. Our work doesn’t stop when we close the lab door or analyse the last sample. Always looking for the next discovery, the next innovation – now and into the future.

King Salman Hospital in Riyadh: Pioneering healthcare excellence in Saudi Arabia

Established in 1984, King Salman Hospital in Riyadh has long been a cornerstone of medical care in Saudi Arabia, serving over 3 million residents in western Riyadh.

Over the past two years, King Salman Hospital (KSH) has achieved transformative milestones aligned with its strategy to improve access to healthcare and build strong service integration driven by efficiency and effectiveness. During the previous 2 years, KSH has achieved a lot of remarkable improvements in multiple Key Performance Indicators (KPIs) aligned with the facility’s strategic goals.

Reducing ICU stay times

The Adult Intensive Care Unit (ICU) at KSH faced challenges of high utilisation and prolonged patient stays, straining its 13bed capacity. To address this, the hospital launched a six-bed step-down unit in mid2023, designed to transition stabilised ICU patients to intermediate care.

The implementation strategy involved a multidisciplinary team mapping resources, staffing, and workflows; a three-month trial where patient outcomes, readmissions, and workflow efficiency were monitored; and a full integration where adjustments based on pilot data optimised staffing and protocols.

The average length of stay plummeted from 6.1 days in 2022 to 3.1 days by late 2024—a 49% reduction—surpassing the initial target of 4 days. This not only improved bed turnover but also reduced costs.

Revolutionising patient access

KSH’s Virtual Digital Health Centre, launched via platforms like Sehhaty and Anat, has redefined non-emergency care delivery. By offering teleconsultations and remote followups, the hospital slashed unnecessary physical visits and expanded access.

Following this, there has been a 540% surge in virtual appointments between 2023 and 2024, whilst patient satisfaction scores rose by 11% from Q1 2023 to Q3 2024.

The centre’s success lies in its structured workflow, which integrates physician support, telehealth tools, and continuous feedback. By 2024, virtual services accounted for 21% of total outpatient interactions, easing pressure on physical facilities.

Surgical capacity expansion

To address the growing demand, KSH targeted 7,000 annual surgeries by 2024. Through strategic initiatives, the hospital not only met but exceeded this goal, performing

8,207 procedures by December 2024.

Amongst its key strategies were extended hours, collaborative networks and specialised units. Evening shifts (until 10 PM) and weekend operations maximised OR utilisation. Partnerships with Riyadh First Health Cluster hospitals, like Al-Iman hospital, expanded surgical capacity. Lastly, a new ophthalmology minor OR streamlined high-volume procedures.

This 17% surge in surgical throughput reduced wait times and enhanced access to life-saving interventions, reinforcing KSH’s role as a regional surgical hub.

Also, KSH in Riyadh has earned international recognition by winning the Healthcare Asia Award 2025 as the Clinical Service Initiative of the Year - Saudi Arabia. The award underscores KSH’s pioneering work in combating one of the region’s most pressing public health concerns—obesity.

Obesity has become an epidemic in the Kingdom, driven by sedentary lifestyles, dietary changes, and urbanisation. Recognising the long-term implications of this crisis, including its links to diabetes, cardiovascular disease, and cancer, KSH launched a comprehensive obesity strategy as part of its broader Population Health Management Plan.

The Obesity unit in KSH uses a comprehensive assessment process

that includes medical history, lifestyle behaviours, and biometric data to identify high-risk populations. Each patient’s journey is customised, starting with data-driven risk stratification using biometric and behavioural health metrics.

One of the programme’s most notable achievements is the 330% increase in bariatric surgeries between 2018 and 2024. In 2024 alone, over 277 surgeries were performed, supported by more than 1,100 outpatient clinic visits, all facilitated through an integrated electronic medical record system and digital referral tools.

A

vision for tomorrow

King Salman Hospital’s achievements reflect its commitment to innovation and patient-centred care. As it eyes future goals, the hospital remains a beacon of progress, embodying Saudi Arabia’s vision for a healthier, technologically advanced society.

The hospital slashed unnecessary physical visits and expanded access
King Salman Hospital
The multidisciplinary team behind KSH in Riyadh

SERVICE INNOVATION OF THE YEAR - THAILAND

COVID-19 causes cancers by genomic integrations

Innovation Discovery 2025 by Femto Research Group Company

Therehave been reported 7,090,763 confirmed COVID-induced deaths and 675,619,811 recovered, worldwide. The rise of new cancers, recurrence, and aggressively advanced and cancer death cases are reported amongst those who had survived COVID-19.

The emergence of cancer and COVID-19 comorbidity are increasingly noticeable.

Studies are emerging, indicating the SARS-CoV-2 infections will ultimately lead to the development of various cancers. A variety of mechanisms have been proposed, but without any molecular evidence to confirm in living humans.

During COVID-19 pandemic, our *p53DIICBiome© innovation service incidentally stumbled upon the solid evidence, i.e., the SARS-CoV-2 integrations in living human genomes (23%, N=206). Most of them

*p53DIICBiome©innovations,identifyingcancer-related genomeinfections,consecutivelywontheHealthcareAsia AwardforServiceInnovationoftheYear-Thailandfor sevenyears.Thisserviceisnon-invasive.Youcansenddried salivatoFemtoLab©foragenometestbypostage.

are cancer patients. “This is the first report in which the SARS-CoV-2 was found to integrate living human genomes, causing DNA changes

and leading to cancers.”

The patients with the COVID-19 infection are at high risk of cancers and complications. Identification of damaged viral-integrated DNA by *p53DIICBiome© should likely benefit the COVID-19 survivors, i.e., for the sake of prevention and management.

CONTACT

Femto Research Group Co.,Ltd

Email: kliupsornsuddhibhaga@gmail.com

Mobiles: +66659563733; +66642878989

Saliva collection method: https://www. youtube.com/watch?v=HlKav_R07hs

Femto Research Group Co., Ltd.

RAAKHI SIPPY

Why preventing diseases through adult immunisation is essential to keeping Singaporeans healthy

People are living longer thanks to modern medicine. Diseases that once caused suffering or even death, like smallpox and polio, have now been eradicated or controlled due to advances in vaccines, antibiotics and medical technology. However, as life spans increase, healthcare needs to become more complex with a rising burden of chronic diseases. This is especially true in Singapore, where the ageing population is growing fast.

By 2030, nearly 25% of the population will be 65 or over, compared to the current 14%. With weaker immune systems as we age, an older population is more susceptible to infectious and chronic diseases leading to increased healthcare costs for the country.

Shifting from reactive treatment to prevention

The challenge is that healthcare systems prioritise treatment over prevention, with only 2.7% of the total healthcare spending dedicated to prevention. The fallout is that many people contract and live with diseases that could have been easily prevented, and individuals, families, and healthcare systems must bear the burden of those consequences. Investing in prevention improves health outcomes and is generally costeffective for economies as every dollar invested in improving one’s health can generate an economic return of twice to four times the investment. This makes a clear case that moving from funding treatment-oriented systems to preventive care can deliver positive health impacts.

A Singaporean caregiver shared how her elderly mother was hospitalised due to a vaccine-preventable respiratory disease, “The challenge goes beyond the illness itself — it is the sleepless nights, the constant worry, and the disruption to daily life… the financial strain is just as overwhelming as the emotional toll. Hospital bills, medication costs, and the possibility of long-term care can quickly add up, leaving families financially drained, on top of the stress of caring for a loved one.” Mr. Ong Ye Kung, Singapore Minister for Health, has emphasised shifting the country’s healthcare system, “to focus on preventive care instead of curative care, emphasise health instead of sickness, shift the centre of gravity of care away from hospitals into the community.”

Whilst progress has been achieved, Singapore must leverage opportunities to become a prevention-first nation.

Prevention-focused healthcare system

Whilst Singaporeans are familiar with the National Childhood Immunisation Schedule, awareness of the National Adult Immunisation Schedule remains low. This is reflected in the uptake of pneumococcal vaccination in the country with 35% amongst adults aged 65-74 in 2023, compared to more than 90% for children in 2022.

What’s more, as of June 2024, only about 15% of seniors aged 60 or older have received more than four doses of COVID-19 vaccinations according to the MOH. As a result, millions of adults are vulnerable to vaccine-preventable diseases, increasing hospitalisations and medical complications.

Just as a healthy diet and exercise improves wellbeing, adult immunisation can reduce common but high-burden diseases like

influenza, respiratory viruses, shingles, and pneumonia, which can severely affect older adults. Immunisation across the life course not only prevents 3.5 to 5 million deaths globally every year but also reduces healthcare and socioeconomic costs. The UK-based Office of Health Economics found that every dollar invested in adult immunisation programmes can generate up to 19 times in socioeconomic returns.

The need for adult immunisation

Singapore has already started moving towards a prevention-first mindset with initiatives like Healthier SG, which encourages healthy habits, such as regular exercise, balanced diets, and good sleep. However, the journey doesn’t stop there. As some diseases are vaccinepreventable, policies in HSG must continue to evolve to provide adults with additional layers of protection. Strengthening the current adult immunisation programmes is a cost-effective step for Singapore to become a prevention-first nation.

A prevention-first mindset is also required, including collective action from individuals and organisations. Educators, business owners, and healthcare workers, all play a role in promoting health and wellbeing. Change starts with each person choosing prevention over reaction, creating a ripple effect that benefits communities, societies and governments. Ongoing research and innovation are also essential to address emerging health threats and support healthy ageing. Investing in new vaccines and preventive technologies will help Singaporeans stay active, healthy, and engaged for years to come.

The benefits of shifting to prevention-first healthcare, including adult immunisation, are clear — reducing disease incidence, hospital admission, and healthcare costs while increasing quality of life. If Singapore achieves even a 10% to 20% increase in adult immunisation rates, it could free up resources for other critical areas like chronic disease management and long-term care. By prioritising adult immunisation and enabling policies, Singapore can lead in preventive healthcare, ensuring healthier lives and a more sustainable healthcare system for the future.

Only 15% of seniors have received over four doses of COVID-19 vaccinations

RONITA MUKERJEE OPINION

Strategic brand & design: A smart prescription to drive growth in healthcare

COVID was an inflection point for global health. A major shift we observed was consumer agency in their health decisions.

Good health is not just an outcome; it is an active and ongoing pursuit. Empowered by information and digital access, consumers expect holistic, personalised and preventive healthcare.

But in the Asia-Pacific region, this pursuit comes with many challenges, such as limited access, stigma around mental health, shortage of qualified health care professionals, and uneven digital adoption.

As healthcare brands ramp up their research and development (R&D) capabilities to adapt to new technology, shifting business models and regulatory changes; they must ask themselves first– “Are we truly leveraging all our business assets to create value?”

One of the most overlooked assets is brand.

Traditionally, healthcare has prioritised efficacy, compliance, and safety. They are essential, but not differentiating.

Brands, when strategically leveraged through design and experience, can become a unifying force connecting R&D, culture, customer experience, and business ambition.

We have already seen the power of a brand-led approach.

For example, GE Healthcare has evolved into a brand and designdriven company with emphasis on design thinking which led to the development of Adventure Series Radiology solutions, resulting in improved patient experience, operational efficiency, and reduced costs. If something as clinical as an MRI scan can be transformed through brand-led innovation, what other overlooked moments in healthcare

can become opportunities for reinvention and impact?

Cleveland Clinic’s physical spaces are designed to decrease patient anxiety through minimalist architecture, intuitive navigation, and natural light. Hallways and waiting rooms can ease patient anxiety, so why not design every step of the patient journey with intent and care?

Meanwhile, Arogya designed a pictogram-based medicine packaging for the rural, low literacy population in India.

Small but meaningful design shifts can drive large scale impact in adherence and chronic disease care.

Over 1 billion people worldwide experience some form of disability. How can we leverage colour, visual brand language, form, and verbal identity to make our products more inclusive?

Lastly, Johnson & Johnson has leveraged design thinking and cultural insights to overcome the mental health crisis in Asia. By adopting a mobile-first approach and creating a narrative around “wellbeing” and “resilience” instead of using clinical language, they have been able to lower stigma and encourage early engagement.

As global brands navigate diverse markets, it becomes deeply important to design for cultural nuances. These examples show that strategic brand and design are not cosmetic, but are powerful levers for business transformation that will drive growth.

In an area as diverse as Asia-Pacific region, the opportunity is to reimagine healthcare not just through innovation in science and technology, but through the lens of brand to elevate healthcare from functional to transformative.

Cleveland Clinic's physical spaces are designed to decrease patient anxiety (Photo from PLP Architecture)
Kid-friendly MRI scanners (Photo from GE Healthcare)

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.